SWBI Smith and Wesson Brands Inc

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2023

Commission File No. 001-31552

 

 

 

Smith & Wesson Brands, Inc.

(Exact name of registrant as specified in its charter)

Nevada		87-0543688
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2100 Roosevelt Avenue Springfield, Massachusetts		01104
(Address of principal executive offices)		(Zip Code)

(800) 331-0852

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class	Trading Symbol	Name of exchange on which registered
Common Stock, par value $0.001 per share	SWBI	Nasdaq Global Select Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer		☐		Accelerated filer			☒
Non-accelerated filer		☐		Smaller reporting company			☐
Emerging growth company		☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had 45,639,351 shares of common stock, par value $0.001, outstanding as of December 5, 2023.

 

---

 

SMITH & WESSON BRANDS, INC.

Quarterly Report on Form 10-Q

For the Three and Six Months Ended October 31, 2023 and 2022

 

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
	Item 1. Financial Statements (Unaudited)		4
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		20
	Item 3. Quantitative and Qualitative Disclosures About Market Risk		26
	Item 4. Controls and Procedures		26
PART II - OTHER INFORMATION
	Item 1. Legal Proceedings		27
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		27
	Item 5. Other Information		27
	Item 6. Exhibits		27
Signatures			29
EX-10.137
EX-31.1
EX-31.2
EX-32.1
EX-32.2

 

Smith & Wesson®, S&W®, M&P®, M&P Shield®, Performance Center®, Airlite®, Airweight®, American Guardians®, America’s Master Gunmaker®, Armornite®, Arrow®, Aurora®, Aurora-II®, Blast Jacket®, Bodyguard®, Carry Comp®, Chiefs Special®, Club 1852®, Compass®, Competitor®, Contender®, CSX®, Dagger®, Encore®, E-Series®, EZ®, Flextech®, G-Core®, Gemtech®, Gemtech Suppressors®, Gemtech World-Class Silencers®, GM®, GM-S1®, GMT-Halo®, Governor®, Integra®, Lady Smith®, Lever Lock®, Lunar®, M&P FPC®, M2.0®, Mag Express®, Magnum®, Maxi-Hunter®, Mist-22®, Mountain Gun®, Number 13®, PC®, Power Rod®, Protected by Smith & Wesson®, Put A Legend On Your Line®, QLA®, Quick Load Accurizor®, Quickmount®, Shield®, Smith & Wesson Collectors Association®, Smith & Wesson Performance Center®, Smith & Wesson Precision Components®, Speed Breech®, Speed Breach XT®, SW Equalizer®, SW22 Victory®, Swing Hammer®, T/C®, T/CR22®, T17®, The S&W Bench®, The Sigma Series®, Thompson/Center®, Trek®, Triumph®, U-View®, Volunteer®, and Weather Shield® are some of the registered U.S. trademarks of our company or one of our subsidiaries. This report also may contain trademarks and trade names of other companies.

 

---

 

Statement Regarding Forward-Looking Information

The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained or incorporated herein by reference in this Quarterly Report on Form 10-Q, including statements regarding our future operating results, future financial position, business strategy, objectives, goals, plans, prospects, markets, and plans and objectives for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “targets,” “contemplates,” “projects,” “predicts,” “may,” “might,” “plan,” “will,” “would,” “should,” “could,” “may,” “can,” “potential,” “continue,” “objective,” or the negative of those terms, or similar expressions intended to identify forward-looking statements. However, not all forward-looking statements contain these identifying words. Specific forward-looking statements in this Quarterly Report on Form 10-Q include statements regarding our intention to terminate the Missouri Sublease (as defined herein) on or around the effective date of the Assignment and Assumption Agreement (as defined herein); our intention to occupy our Connecticut facility at least through May 4, 2024, the end of the current lease term; that we may seek to extend the lease for the Connecticut facility through the end of calendar 2024; our belief that there are no indications of impairment relating to right-of-use assets; expected undiscounted cashflows, based on the Missouri Sublease, for future periods; lease payments for all our operating and finance leases for future periods; the outcome of the lawsuits to which we are subject and their effect on us; our belief that the remaining claims asserted by Gemini (as defined herein) and plaintiffs in a putative class action against us have no merit and that we intend to aggressively defend these actions; our belief with respect to certain matters described in the Commitments and Contingencies – Litigation section, that the allegations are unfounded and that any incident and any results from them or any injuries were due to negligence or misuse of the firearm by the claimant or a third party; our belief that our accruals for product liability cases and claims are a reasonable quantitative measure of the cost to us of product liability cases and claims; our belief that we have provided adequate accruals for defense costs; our intention, in connection with our new facility in Maryville, Tennessee, to incur, or cause to be incurred, no less than $120.0 million in aggregate capital expenditures on or before December 31, 2025, create no less than 620 new jobs, and sustain an average hourly wage of at least $25.97 at the facility; our expectation, when adding the cost of machinery and equipment, to spend between $160.0 million and $170.0 million through the end of fiscal 2024; our intention, with respect to assets associated with our assembly operations in Massachusetts, to either move those assets to the Tennessee facility at the appropriate time or sell or sublease those assets that will not be moved; our expectation that subsequent to the Relocation, our Massachusetts facility will continue to remain an important part of our manufacturing activities with significant portions of the operations being unaffected by the Relocation; our intention to relocate a portion of our plastic injection molding operations to the Tennessee facility and evaluate selling the remaining molding operations utilized in our Connecticut facility to a third party; our intention to continue to evaluate possible losses associated with any impairment of the Connecticut facility assets as we determine which assets may be sold; our belief that inventory levels, both internally and in the distribution channel, in excess of demand may negatively impact future operating results; our expectation that our inventory levels will decline by the end of the fiscal year due to the completion of a significant portion of the operational transition to the new Tennessee facility combined with alignment of production capacity to channel inventory and consumer demand; our expectation for capital expenditures in fiscal 2024, excluding payments related to the Relocation; factors affecting our future capital requirements; availability of equity or debt financing on acceptable terms, if at all; the record date and payment date for our dividend; and our belief that our existing capital resources and credit facilities will be adequate to fund our operations, including our finance leases and other commitments, for the next 12 months. All forward-looking statements included herein are based on information available to us as of the date hereof and speak only as of such date. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. The forward-looking statements contained in or incorporated by reference into this Quarterly Report on Form 10-Q reflect our views as of the date hereof about future events and are subject to risks, uncertainties, assumptions, and changes in circumstances that may cause our actual results, performance, or achievements to differ significantly from those expressed or implied in any forward-looking statement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, performance, or achievements. A number of factors could cause actual results to differ materially from those indicated by the forward-looking statements. Such factors include, among others, economic, political, social, legislative, regulatory, inflationary, and health factors; the potential for increased regulation of firearms and firearm-related products; actions of social activists that could have an adverse effect on our business; the impact of lawsuits; the demand for our products; the state of the U.S. economy in general and the firearm industry in particular; general economic conditions and consumer spending patterns; our competitive environment; the supply, availability, and costs of raw materials and components; speculation surrounding fears of terrorism and crime; our anticipated growth and growth opportunities; our ability to effectively manage and execute the Relocation; our ability to increase demand for our products in various markets, including consumer, law enforcement, and military channels, domestically and internationally; our penetration rates in new and existing markets; our strategies; our ability to maintain and enhance brand recognition and reputation; our ability to introduce new products; the success of new products; our ability to expand our markets; the potential for cancellation of orders from our backlog; and other factors detailed from time to time in our reports filed with the Securities and Exchange Commission, or the SEC, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2023, or the Fiscal 2023 Form 10-K.

 

---

 

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

		As of:
		October 31, 2023				April 30, 2023
		(In thousands, except par value and share data)
ASSETS
Current assets:
Cash and cash equivalents		$	44,192			$	53,556
Accounts receivable, net of allowances for credit losses of $22 on    October 31, 2023 and $23 on April 30, 2023			59,773				55,153
Inventories			163,291				177,118
Prepaid expenses and other current assets			9,870				4,917
Income tax receivable			4,713				1,176
Total current assets			281,839				291,920
Property, plant, and equipment, net			253,253				210,330
Intangibles, net			2,823				3,588
Goodwill			19,024				19,024
Deferred income taxes			8,085				8,085
Other assets			7,949				8,347
Total assets		$	572,973			$	541,294
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	44,536			$	36,795
Accrued expenses and deferred revenue			23,197				20,149
Accrued payroll and incentives			19,889				18,565
Accrued income taxes			190				1,831
Accrued profit sharing			1,504				8,203
Accrued warranty			1,578				1,670
Total current liabilities			90,894				87,213
Notes and loans payable (Note 4)			64,836				24,790
Finance lease payable, net of current portion			36,209				36,961
Other non-current liabilities			7,532				7,707
Total liabilities			199,471				156,671
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized, no shares    issued or outstanding			—				—
Common stock, $0.001 par value, 100,000,000 shares authorized, 75,322,622 shares    issued and 45,636,482 shares outstanding on October 31, 2023 and 75,029,300    shares issued and 45,988,930 shares outstanding on April 30, 2023			75				75
Additional paid-in capital			286,341				283,666
Retained earnings			517,682				523,184
Accumulated other comprehensive income			73				73
Treasury stock, at cost (29,686,140 shares on October 31, 2023 and    29,040,370 shares on April 30, 2023)			(430,669	)			(422,375	)
Total stockholders’ equity			373,502				384,623
Total liabilities and stockholders' equity		$	572,973			$	541,294

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

---

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

 

	For the Three Months Ended October 31,								For the Six Months Ended October 31,
	2023				2022				2023				2022
	(In thousands, except per share data)
Net sales	$	124,958			$	121,035			$	239,201			$	205,429
Cost of sales		93,192				81,773				177,034				134,696
Gross profit		31,766				39,262				62,167				70,733
Operating expenses:
Research and development		1,724				1,869				3,522				3,542
Selling, marketing, and distribution		10,952				9,431				20,993				17,458
General and administrative		15,322				15,435				29,536				33,288
Total operating expenses		27,998				26,735				54,051				54,288
Operating income		3,768				12,527				8,116				16,445
Other income/(expense), net:
Other income/(expense), net		141				790				188				1,463
Interest (expense)/income, net		(646	)			(420	)			(492	)			(854	)
Total other (expense)/income, net		(505	)			370				(304	)			609
Income from operations before income taxes		3,263				12,897				7,812				17,054
Income tax expense		765				3,249				2,196				4,094
Net income	$	2,498			$	9,648			$	5,616			$	12,960
Net income per share:
Basic - net income	$	0.05			$	0.21			$	0.12			$	0.28
Diluted - net income	$	0.05			$	0.21			$	0.12			$	0.28
Weighted average number of common shares outstanding:
Basic		45,977				45,815				46,042				45,777
Diluted		46,361				46,106				46,458				46,104

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

---

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

																		Accumulated
		Common								Additional								Other												Total
		Stock								Paid-In				Retained				Comprehensive				Treasury Stock								Stockholders’
(In thousands)		Shares				Amount				Capital				Earnings				Income				Shares				Amount				Equity
Balance at July 31, 2022			74,811			$	75			$	278,297			$	503,376			$	73				29,040			$	(422,375	)		$	359,446
Stock-based compensation			—				—				1,428				—				—				—				—				1,428
Shares issued under employee stock purchase plan			85				—				753				—				—				—				—				753
Issuance of common stock under restricted   stock unit awards, net of shares   surrendered			39				—				(58	)			—				—				—				—				(58	)
Dividends issued			—				—				—				(4,577	)			—				—				—				(4,577	)
Net income			—				—			—					9,648				—				—				—				9,648
Balance at October 31, 2022			74,935			$	75			$	280,420			$	508,447			$	73				29,040			$	(422,375	)		$	366,640
Balance at April 30, 2022			74,641			$	75			$	278,101			$	504,640			$	73				29,040			$	(422,375	)		$	360,514
Stock-based compensation			—				—				2,605				—				—				—				—				2,605
Shares issued under employee   stock purchase plan			85				—				753				—				—				—				—				753
Issuance of common stock under restricted   stock unit awards, net of shares   surrendered			209				—				(1,039	)			—				—				—				—				(1,039	)
Dividends issued		—				—				—					(9,153	)		—				—				—					(9,153	)
Net income			—				—			—					12,960				—				—				—				12,960
Balance at October 31, 2022			74,935			$	75			$	280,420			$	508,447			$	73				29,040			$	(422,375	)		$	366,640
Balance at July 31, 2023			75,184			$	75			$	284,176			$	520,766			$	73				29,040			$	(422,375	)		$	382,715
Stock-based compensation			—				—				1,484				—				—				—				—				1,484
Shares issued under employee   stock purchase plan			83				—				722				—				—				—				—				722
Issuance of common stock under restricted   stock unit awards, net of shares   surrendered			56				—				(41	)			—				—				—				—				(41	)
Repurchase of treasury stock		—				—				—				—				—					646				(8,294	)			(8,294	)
Unpaid dividends accrued			—				—				—				(38	)			—				—				—				(38	)
Dividends issued		—				—					—				(5,544	)		—				—				—					(5,544	)
Net income			—				—			—					2,498				—				—				—				2,498
Balance at October 31, 2023			75,323			$	75			$	286,341			$	517,682			$	73				29,686			$	(430,669	)		$	373,502
Balance at April 30, 2023			75,029			$	75			$	283,666			$	523,184			$	73				29,040			$	(422,375	)		$	384,623
Stock-based compensation			—				—				2,759				—				—				—				—				2,759
Shares issued under employee   stock purchase plan			83								722				—				—				—				—				722
Issuance of common stock under restricted    stock unit awards, net of shares    surrendered			211				—				(806	)			—				—				—				—				(806	)
Repurchase of treasury stock		—				—				—				—				—					646				(8,294	)			(8,294	)
Unpaid dividends accrued			—				—				—				(38	)			—				—				—				(38	)
Dividends issued		—				—				—					(11,080	)		—				—				—					(11,080	)
Net income			—				—			—					5,616				—				—				—				5,616
Balance at October 31, 2023			75,323			$	75			$	286,341			$	517,682			$	73				29,686			$	(430,669	)		$	373,502

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

---

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

		For the Six Months Ended October 31,
		2023				2022
		(In thousands)
Cash flows from operating activities:
Net income		$	5,616			$	12,960
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Depreciation and amortization			17,327				15,171
Loss/(gain) on sale/disposition of assets			682				(43	)
Provision for recoveries on notes and accounts receivable			(1	)			(13	)
Stock-based compensation expense			2,759				2,605
Changes in operating assets and liabilities:
Accounts receivable			(4,619	)			18,324
Inventories			13,827				(59,814	)
Prepaid expenses and other current assets			(4,953	)			(2,493	)
Income taxes			(5,178	)			(11,555	)
Accounts payable			14,682				5,889
Accrued payroll and incentives			1,324				(329	)
Accrued profit sharing			(6,699	)			(7,915	)
Accrued expenses and deferred revenue			2,859				307
Accrued warranty			(92	)			(130	)
Other assets			397				521
Other non-current liabilities			(175	)			(1,650	)
Net cash provided by/(used in) operating activities			37,756				(28,165	)
Cash flows from investing activities:
Payments to acquire patents and software			(125	)			(256	)
Proceeds from sale of property and equipment			45				85
Payments to acquire property and equipment			(66,983	)			(39,419	)
Net cash used in investing activities			(67,063	)			(39,590	)
Cash flows from financing activities:
Proceeds from loans and notes payable			50,000				—
Payments on notes and loans payable			(10,000	)			—
Payments on finance lease obligation			(681	)			(559	)
Payments to acquire treasury stock			(8,212	)			—
Dividend distribution			(11,080	)			(9,153	)
Proceeds to acquire common stock from employee stock purchase plan			722				753
Payment of employee withholding tax related to    restricted stock units			(806	)			(1,039	)
Net cash provided by/(used in) financing activities			19,943				(9,998	)
Net decrease in cash and cash equivalents			(9,364	)			(77,753	)
Cash and cash equivalents, beginning of period			53,556				120,728
Cash and cash equivalents, end of period		$	44,192			$	42,975
Supplemental disclosure of cash flow information
Cash paid for:
Interest, net of amounts capitalized		$	1,725			$	1,089
Income taxes		$	7,353			$	15,721

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

---

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - (Continued)

(Unaudited)

 

Supplemental Disclosure of Non-cash Investing Activities:

 

		For the Six Months Ended October 31,
		2023				2022
		(In thousands)
Purchases of property and equipment included in accounts payable		$	8,826			$	9,655
Capital lease included in accrued expenses and finance lease payable			694			—

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

---

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and Six Months Ended October 31, 2023 and 2022

 

12

---

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Three and Six Months Ended October 31, 2023 and 2022

 

 

 

19

---

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Please refer to the Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Fiscal 2023 Annual Report and our unaudited condensed consolidated financial statements included in Item 1 of this Quarterly Report on Form 10-Q. This section sets forth key objectives and performance indicators used by us as well as key industry data tracked by us.

Second Quarter Fiscal 2024 Highlights

Our operating results for the three months ended October 31, 2023 included the following:

Our operating results for the six months ended October 31, 2023 included the following:

During the six months ended October 31, 2023, we purchased 645,770 shares of our common stock for $8.2 million, utilizing cash on hand.

 

Results of Operations

Net Sales and Gross Profit – For the Three Months Ended October 31, 2023

The following table sets forth certain information regarding net sales and gross profit for the three months ended October 31, 2023 and 2022 (dollars in thousands):

 

	2023				2022				$ Change				% Change
Handguns	$	88,347			$	93,037			$	(4,690	)			-5.0	%
Long Guns		28,120				16,999				11,121				65.4	%
Other Products & Services		8,491				10,999				(2,508	)			-22.8	%
Total net sales	$	124,958			$	121,035			$	3,923				3.2	%
Cost of sales		93,192				81,773				11,419				14.0	%
Gross profit	$	31,766			$	39,262			$	(7,496	)			-19.1	%
% of net sales (gross margin)		25.4	%			32.4	%

 

The following table sets forth certain information regarding firearm units shipped by trade channel for the three months ended October 31, 2023 and 2022 (units in thousands):

 

Total Units Shipped		2023				2022				# Change				% Change
Handguns			191				209				(18	)		-8.6%
Long Guns			56				31				25			80.6%
Sporting Goods Channel Units Shipped		2023				2022				# Change				% Change
Handguns			177				191				(14	)		-7.3%
Long Guns			53				27				26			96.3%
Professional Channel Units Shipped		2023				2022				# Change				% Change
Handguns			14				18				(4	)		-22.2%
Long Guns			3				4				(1	)		-25.0%

 

20

---

 

Sales of our handguns decreased $4.7 million, or 5.0%, from the comparable quarter last year, primarily due to lower demand for several of our older handgun products and certain products that were introduced in the prior year, partially offset by increased shipments of newly introduced products (defined as any new SKU not shipped in the comparable quarter last year), which represented 21.7% of handgun sales in the period. Handgun unit shipments into the sporting goods channel decreased by 7.3% from the comparable quarter last year while overall consumer handgun demand decreased 7.9% (as indicated by adjusted background checks reported in the National Instant Criminal Background Check System, or NICS).

Sales of our long guns increased $11.1 million, or 65.4%, over the comparable quarter last year, primarily due to increased shipments of newly introduced products, which represented 60.7% of long gun sales in the period. Long gun unit shipments into our sporting goods channel increased 96.3% from the comparable quarter last year while overall consumer demand for long guns remained relatively flat, as indicated by NICS.

Other products and services revenue decreased $2.5 million, or 22.8%, from the comparable quarter last year, primarily because of decreased sales of component parts, decreased licensing revenue, and decreased business-to-business services.

New products represented 29.0% of sales for the three months ended October 31, 2023 and included two new pistols, one new long gun, and many new product line extensions.

Gross margin for the three months ended October 31, 2023 was 25.4% compared with gross margin of 32.4% for the comparable quarter last year, primarily because of a combination unfavorable fixed-cost absorption (due to lower production volume), the impact of an accrued legal settlement for $3.2 million, the impact of inflation on raw materials and finished parts, which increased approximately 5.0% over the prior year comparable quarter, the impact of inflation on labor costs, (particularly as it relates to entry level positions), and unfavorable inventory reserve adjustments, including capitalized variances, partially offset by decreased spend on the Relocation and a mix of new products at higher prices.

Inventory balances decreased $13.8 million between April 30, 2023 and October 31, 2023. While inventory levels, both internally and in the distribution channel, in excess of demand may negatively impact future operating results, it is difficult to forecast the potential impact of distributor inventories on future revenue and income as demand is impacted by many factors, including seasonality, new product introductions, news events, political events, and consumer tastes. We expect our inventory levels will decline by the end of the fiscal year due to the completion of a significant portion of the operational transition to the new Tennessee facility combined with alignment of production capacity to channel inventory and consumer demand.

Net Sales and Gross Profit – For the Six Months Ended October 31, 2023

The following table sets forth certain information regarding net sales and gross profit for the six months ended October 31, 2023 and 2022 (dollars in thousands):

		2023				2022				$ Change				% Change
Handguns		$	174,452			$	152,403			$	22,049				14.5	%
Long Guns			46,903				31,105				15,798				50.8	%
Other Products & Services			17,846				21,921				(4,075	)			-18.6	%
Total net sales		$	239,201			$	205,429			$	33,772				16.4	%
Cost of sales			177,034				134,696				42,338				31.4	%
Gross profit		$	62,167			$	70,733			$	(8,566	)			-12.1	%
% of net sales (gross margin)			26.0	%			34.4	%

 

21

---

 

The following table sets forth certain information regarding firearm units shipped by trade channel for the six months ended October 31, 2023 and 2022 (units in thousands):

Total Units Shipped		2023				2022				# Change				% Change
Handguns			365				337				28			8.3%
Long Guns			95				58				37			63.8%
Sporting Goods Channel Units Shipped		2023				2022				# Change				% Change
Handguns			339				307				32			10.4%
Long Guns			86				51				35			68.6%
Professional Channel Units Shipped		2023				2022				# Change				% Change
Handguns			26				30				(4	)		-13.3%
Long Guns			9				7				2			28.6%

Sales of our handguns increased $22.0 million, or 14.5%, over the prior year comparable period. The increase in sales was primarily due to increased shipments of our revolvers, increased shipments of newly introduced products, which represented 25.7% of handgun sales in the period, as well as a 5% price increase on select products that became effective in the second quarter of fiscal 2023. Handgun unit shipments into the sporting goods channel increased by 10.4% over the comparable period last year while overall consumer handgun demand decreased 10.8% (as indicated by NICS).

Sales of our long guns increased $15.8 million, or 50.8%, over the prior year comparable period, primarily due to increased shipments of newly introduced products, which represented 61.5% of long gun sales in the period. Long gun unit shipments into our sporting goods channel increased 68.6% over the comparable period last year while overall consumer demand for long guns decreased 6.6%, as indicated by NICS.

Other products and services revenue decreased $4.1 million, or 18.6%, from the prior year comparable period, primarily because of decreased sales of component parts, decreased business-to-business services, and decreased licensing revenue, partially offset by increased sales of handcuffs.

New products represented 30.8% of sales for the six months ended October 31, 2023 and included five new pistols, two new long guns, and many new product line extensions.

Gross margin for the six months ended October 31, 2023 was 26.0% compared with gross margin of 34.4% for the comparable period last year for similar reasons outlined above for the three months ended October 31, 2023, partially offset by a price increase that became effective in the second quarter of fiscal 2023.

Operating Expenses

The following table sets forth certain information regarding operating expenses for the three months ended October 31, 2023 and 2022 (dollars in thousands):

	2023				2022				$ Change				% Change
Research and development	$	1,724			$	1,869			$	(145	)			-7.8	%
Selling, marketing, and distribution		10,952				9,431				1,521				16.1	%
General and administrative		15,322				15,435				(113	)			-0.7	%
Total operating expenses	$	27,998			$	26,735			$	1,263				4.7	%
% of net sales		22.4	%			22.1	%

Research and development expenses decreased $145,000 from the prior year comparable quarter, primarily because of decreased sample and testing costs associated with new product development. Selling, marketing, and distribution expenses increased $1.5 million from the prior year comparable quarter, primarily as a result of one-time costs related to the grand opening event at our new Maryville, Tennessee facility, increased compensation-related costs, and increased spend on targeted customer promotions, partially offset by decreased advertising costs. General and administrative expenses decreased $113,000, primarily because of a $1.1 million decrease in profit sharing expense and decreased costs associated with the Relocation, partially offset by a $1.6 million increase in compensation-related expense. Current year general and administrative expenses were also lower than the prior year comparable quarter due to a change in where the sublease-related income is recorded. During the three months ended October, 31, 2023, sublease-related income of $549,000 was recorded in general and administrative expenses whereas, in fiscal 2023 $565,000 was reported in other income/(expense).

22

---

 

The following table sets forth certain information regarding operating expenses for the six months ended October 31, 2023 and 2022 (dollars in thousands):

		2023				2022				$ Change				% Change
Research and development		$	3,522			$	3,542			$	(20	)			-0.6	%
Selling, marketing, and distribution			20,993				17,458				3,535				20.2	%
General and administrative			29,536				33,288				(3,752	)			-11.3	%
Total operating expenses		$	54,051			$	54,288			$	(237	)			-0.4	%
% of net sales			22.6	%			26.4	%

Selling, marketing, and distribution expenses increased $3.5 million, primarily as a result of a $1.9 million impairment on distribution equipment related to the Relocation, one-time costs related to the grand opening event at our new Maryville, Tennessee facility, increased compensation-related costs, and increased spend on targeted customer promotions, partially offset by decreased digital advertising costs. General and administrative expenses decreased $3.7 million, primarily because of a $3.8 million decrease in profit sharing expense, a $1.0 million decrease in legal-related expenses, and decreased costs associated with the Relocation, partially offset by a $2.4 million increase in compensation-related expenses. During the six months ended October, 31, 2023, sublease-related income of $1.0 million was recorded in general and administrative expenses whereas, in fiscal 2023 $1.1 million was reported in other income/(expense).

Operating Income

The following table sets forth certain information regarding operating income for the three months ended October 31, 2023 and 2022 (dollars in thousands):

	2023				2022				$ Change				% Change
Operating income	$	3,768			$	12,527			$	(8,759	)			-69.9	%
% of net sales (operating margin)		3.0	%			10.3	%

 

Operating income for the three months ended October 31, 2023 decreased $8.8 million from the comparable quarter last year, primarily because of unfavorable fixed-cost absorption, unfavorable inventory reserve adjustments (including amortization of capitalized variances), the impact of an accrued legal settlement, increased compensation-related costs, increase costs on targeted customer promotions, and costs associated with the grand opening of the new Maryville, Tennessee facility, partially offset by increased sales volumes, decreased profit sharing expense, and decreased spend on the Relocation.

The following table sets forth certain information regarding operating income for the six months ended October 31, 2023 and 2022 (dollars in thousands):

		2023				2022				$ Change				% Change
Operating income		$	8,116			$	16,445			$	(8,329	)			-50.6	%
% of net sales (operating margin)			3.4	%			8.0	%

Operating income for the six months ended October 31, 2023 decreased $8.3 million from the prior year comparable period, for reasons outlined above.

Income Taxes

The following table sets forth certain information regarding income tax expense for the three months ended October 31, 2023 and 2022 (dollars in thousands):

	2023				2022				$ Change				% Change
Income tax expense	$	765			$	3,249			$	(2,484	)			-76.5	%
% of income from operations (effective tax rate)		23.4	%			25.2	%							-1.8	%

 

23

---

 

Income tax expense decreased $2.5 million from the comparable quarter last year as a result of lower operating income.

The following table sets forth certain information regarding income tax expense for the six months ended October 31, 2023 and 2022 (dollars in thousands):

		2023				2022				$ Change				% Change
Income tax expense		$	2,196			$	4,094			$	(1,898	)			-46.4	%
% of income from operations (effective tax rate)			28.1	%			24.0	%							4.1	%

Income tax expense decreased $1.9 million from the prior year comparable period as a result of lower operating income.

Net Income

The following table sets forth certain information regarding net income and the related per share data for the three months ended October 31, 2023 and 2022 (dollars in thousands, except per share data):

	2023				2022				$ Change				% Change
Net income	$	2,498			$	9,648			$	(7,150	)			-74.1	%
Net income per share
Basic	$	0.05			$	0.21			$	(0.16	)			-76.2	%
Diluted	$	0.05			$	0.21			$	(0.16	)			-76.2	%

Net income for the three months ended October 31, 2023 was $2.5 million compared with $9.6 million for the comparable quarter last year for the reasons outlined above.

The following table sets forth certain information regarding net income and the related per share data for the six months ended October 31, 2023 and 2022 (dollars in thousands, except per share data):

		2023				2022				$ Change				% Change
Net income		$	5,616			$	12,960			$	(7,344	)			-56.7	%
Net income per share
Basic		$	0.12			$	0.28			$	(0.16	)			-57.1	%
Diluted		$	0.12			$	0.28			$	(0.16	)			-57.1	%

Net income for the six months ended October 31, 2023 was $5.6 million compared with $13.0 million for the prior year comparable period for the reasons outlined above.

Liquidity and Capital Resources

Our principal cash requirements are to (1) finance the growth of our operations, including working capital and capital expenditures, (2) fund the Relocation, and (3) return capital to stockholders. Capital expenditures for the Relocation, new product development, and repair and replacement of equipment represent important cash needs.

The following table sets forth certain cash flow information for the six months ended October 31, 2023 and 2022 (dollars in thousands):

		2023				2022				$ Change				% Change
Operating activities		$	37,756			$	(28,165	)		$	65,921				-234.1	%
Investing activities			(67,063	)			(39,590	)			(27,473	)			-69.4	%
Financing activities			19,943				(9,998	)			29,941				299.5	%
Total cash flow		$	(9,364	)		$	(77,753	)		$	68,389				-88.0	%

 

24

---

 

Operating Activities

On an annual basis, operating activities generally represent the principal source of our cash flows. Cash provided by operating activities was $37.8 million for the six months ended October 31, 2023 compared with $28.2 million of cash used for the six months ended October 31, 2022. Cash provided by operating activities for the six months ended October 31, 2023 was favorably impacted by a $13.8 million decrease in inventory versus a $59.8 million increase in inventory in the prior comparable period. Partially offsetting this was a $4.6 million increase in accounts receivable versus an $18.3 million decrease in accounts receivable in the prior comparable period.

Investing Activities

Cash used in investing activities increased $27.5 million for the six months ended October 31, 2023 compared with the prior year comparable period. We paid $67.0 million for capital expenditures for the six months ended October 31, 2023, $27.6 million higher than the prior year comparable period primarily due to payments related to the Relocation. Excluding payments related to the Relocation, we expect to spend between $20.0 million and $25.0 million on capital expenditures in fiscal 2024.

We expect to spend between $70.0 million and $75.0 million on capital expenditures in fiscal 2024, of which $50.0 million to $55.0 million is expected for the construction of the facility. Through the six months ended October 31, 2023, we have capitalized a portion of the new building, for which we have taken occupancy.

Financing Activities

Cash provided by financing activities was $19.9 million for the six months ended October 31, 2023 compared with a cash use of $10.0 million for the six months ended October 31, 2022. Cash provided by financing activities during the six months ended October 31, 2023 was primarily the result of a net $40 million in borrowings under our revolving line of credit, partially offset by $11.1 million in dividend distributions, and $8.2 million share repurchase. For the six months ended October 31, 2022, cash used in financing activities was primarily the result of $9.2 million in dividend distributions.

Finance Lease – We are a party to a material finance lease, the Missouri Lease which is a $46.2 million lease for our Missouri distribution center that has an effective interest rate of approximately 5.0% and is payable in 240 monthly installments through fiscal 2039. The building is pledged to secure the amounts outstanding. During fiscal 2024, we paid approximately $559,000 in principal payments relating to the Missouri Lease. With the completion of the Separation, we entered into the Missouri Sublease. On July 16, 2022, we entered into an amendment to the Missouri Sublease, increasing the subleased space to 64.7% of the facility under the same terms as the Missouri Lease. On January 31, 2023, we entered into the Assignment and Assumption Agreement and the Amended and Restated Guaranty. We intend to terminate the Missouri Sublease on or around the effective date of the Assignment and Assumption Agreement. Through the three months ended October 31, 2023, we recorded $1.3 million of income related to the Missouri Sublease, of which $722,000 was recorded in general and administrative expenses and $581,000 was recorded in interest income in our condensed consolidated statements of income.

Credit Facilities — We maintain an unsecured revolving line of credit with TD Bank, N.A. and other lenders, or the Lenders, which includes availability up to $100.0 million at any one time, or the Revolving Line. The Revolving Line provides for availability for general corporate purposes, with borrowings to bear interest at either the Base Rate or SOFR rate, plus an applicable margin based on our consolidated leverage ratio, as of October 31, 2023. The credit agreement also provides a swingline facility in the maximum amount of $5.0 million at any one time (subject to availability under the Revolving Line). Each Swingline Loan bears interest at the Base Rate, plus an applicable margin based on our consolidated leverage ratio. In response to a Springing Lien Triggering Event (as defined in the credit agreement), we would be required to enter into certain documents that create in favor of TD Bank, N.A., as administrative agent, and the lenders party to such documents as legal, valid, and enforceable first priority lien on the collateral described therein. Subject to the satisfaction of certain terms and conditions described in the credit agreement, we have an option to increase the Revolving Line by an aggregate amount not exceeding $50.0 million. The Revolving Line matures on the earlier of August 24, 2025, or the date that is six months in advance of the earliest maturity of any permitted notes under the credit agreement. On April 28, 2023, we entered into an amendment to our existing credit agreement to, among other things, replace LIBOR with SOFR as the interest rate benchmark and amend the definition of “Consolidated Fixed Charge Coverage Ratio” to exclude unfinanced capital expenditures in connection with the Relocation.

As of October 31, 2023, we had $65.0 million of borrowings outstanding on the Revolving Line, bearing interest at an average rate of 7.17%, which was equal to the SOFR rate plus an applicable margin.

The credit agreement for our credit facility contains financial covenants relating to maintaining maximum leverage and minimum debt service coverage. We were in compliance with all debt covenants as of October 31, 2023.

25

---

 

Share Repurchase Programs — On September 19, 2023, our Board of Directors authorized the repurchase of up to $50.0 million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. During the three months ended October 31, 2023, we repurchased 645,770 shares of our common stock for $8.2 million under this authorization. There were no common stock purchases through the six months ended October 31, 2022, nor were there any unfulfilled authorizations.

Dividends — In April 2023, our Board of Directors authorized a regular quarterly dividend for stockholders of $0.12 per share, subject to Audit Committee confirmation. The current dividend will be for stockholders of record as of market close on December 21, 2023 and will be payable on January 4, 2024.

Our future capital requirements will depend on many factors, including net sales, the timing and extent of spending to support product development efforts, the expansion of sales and marketing activities, the timing of introductions of new products and enhancements to existing products, the costs to ensure access to adequate manufacturing capacity, and costs related to the Relocation. Further equity or debt financing may not be available to us on acceptable terms or at all. If sufficient funds are not available or are not available on acceptable terms, our ability to take advantage of unexpected business opportunities or to respond to competitive pressures could be limited or severely constrained.

As of October 31, 2023, we had $44.2 million in cash and cash equivalents on hand. Based upon our current working capital position, current operating plans, and expected business conditions, we believe that our existing capital resources and credit facilities will be adequate to fund our operations, including our finance leases and other commitments, for the next 12 months.

Other Matters

Critical Accounting Policies

The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant accounting policies are disclosed in Note 2 of the Notes to the Consolidated Financial Statements in our Fiscal 2023 Annual Report. The most significant areas involving our judgments and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Fiscal 2023 Annual Report, to which there have been no material changes. Actual results could differ from our estimates.

Recent Accounting Pronouncements

The nature and impact of recent accounting pronouncements, if any, is discussed in Note 2—Basis of Presentation to our condensed consolidated financial statements included elsewhere in this report, which is incorporated herein by reference.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

During the period ended October 31, 2023, we did not enter into or transact any forward option contracts nor did we have any forward contracts outstanding.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of October 31, 2023, our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act was recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There was no change in our internal control over financial reporting during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

26

---

 

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

The nature of legal proceedings against us is discussed in Note 9—Commitments and Contingencies to our condensed consolidated financial statements included elsewhere in this report, which is incorporated herein by reference.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth certain information relating to the purchases of our common stock by us and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) under the Exchange Act during the six months ended October 31, 2023 (dollars in thousands, except per share data):

										Total # of Shares				Maximum Dollar
										Purchased as				Value of Shares
										Part of Publicly				that May Yet Be
		Total # of				Average				Announced				Purchased
		Shares				Price Paid				Plans or				Under the Plans
Period		Purchased				Per Share (2)				Programs (1)				or Programs
September 1 to September 30, 2023			554,702			$	12.65				554,702			$	42,973
October 1 to October 31, 2023			91,068				13.00				91,068				41,788
Total			645,770			$	12.70				645,770			$	41,788

 

Item 5. Other Information

Rule 10b5-1 Trading Plans

During the three months ended October 31, 2023, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).

Item 6. Exhibits

The exhibits listed on the Index to Exhibits (immediately preceding the signatures section of this Quarterly Report on Form 10-Q) are included herewith or incorporated herein by reference.

 

27

---

 

INDEX TO EXHIBITS

 

 

10.137		Form of Dividend Equivalent Award Agreement
31.1		Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
31.2		Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
32.1		Section 1350 Certification of Principal Executive Officer
32.2		Section 1350 Certification of Principal Executive officer
101.INS		Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).

 

28

---

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

		SMITH & WESSON BRANDS, INC. a Nevada corporation
Date: December 7, 2023		By:		/s/ Mark P. Smith
				Mark P. Smith
				President and Chief Executive Officer

 

Date: December 7, 2023		By:		/s/ Deana L. McPherson
				Deana L. McPherson
				Executive Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary

 

29

---

Exhibit 10.137

DIVIDEND EQUIVALENTS AWARD AGREEMENT

Eligible Person:

Grant Date: September 19, 2023

This Dividend Equivalents Award Agreement (this “Agreement”), dated as of the Grant Date listed above, is entered into by and between Smith & Wesson Brands, Inc., a Nevada corporation (the “Company”), and the Eligible Person listed above, pursuant to the Smith & Wesson Brands, Inc. 2022 Incentive Stock Plan, as amended from time to time (the “Plan”).

WHEREAS, pursuant to Section 6(g) of the Plan, the Committee is authorized to grant Dividend Equivalents to any Eligible Person entitling the Eligible Person to receive cash, Shares, other Awards, or other property equal in value to the dividends paid with respect to a specified number of Shares, or other periodic payments;

 

WHEREAS, on September 19, 2023, the Committee determined to grant Dividend Equivalents to directors and named executive officers effective immediately with respect to both future and outstanding awards of time-based restricted stock units; and

 

WHEREAS, the Committee has determined that it would be in the best interests of the Company to grant Dividend Equivalents to the Company’s named executive officers with respect to the Eligible Person’s Restricted Stock Unit Awards that are outstanding as of the Grant Date and set forth on Exhibit A (the “Corresponding Awards”).

 

NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows:

1. Incorporation By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan, all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this Agreement will have the same meaning as is ascribed thereto in the Plan. The Eligible Person hereby acknowledges receipt of a true and current copy of the Plan and that the Eligible Person has read the Plan carefully and fully understands its content. In the event of any conflict between the terms of this Agreement and the terms of the Plan, the terms of the Plan will control.

2. Grant of Dividend Equivalents. Effective as of the Grant Date, the Company hereby grants Dividend Equivalents to the Eligible Person equal in number to the Shares underlying the undelivered portion of the Corresponding Awards (each such Share, the “Corresponding Share”). If the Company declares and pays a dividend in respect of its outstanding Shares on or after the Grant Date and, on the record date for such dividend, the Eligible Person holds Corresponding Awards with respect to which Dividend Equivalents have been granted pursuant to this Agreement, then subject to Section 4 below the Eligible Person will be eligible to receive an amount in cash equal to the cash dividends the Eligible Person would have received if the Eligible Person were the holder of record, as of such record date, of the Corresponding Shares. The Eligible Person will have no rights as a stockholder with respect to any Corresponding Shares with respect to Dividend Equivalents unless and until the Eligible Person has become the holder of record of such Shares, and no adjustments will be made for rights in respect of any such Shares, except as otherwise specifically provided for in the Plan or this Agreement.

 

3. Bookkeeping. The Company will establish, with respect to each Corresponding Award, a separate Dividend Equivalent bookkeeping account for such Corresponding Awards, which will be credited (without interest) on the applicable distribution dates with an amount equal to any distributions paid during the period that such Corresponding Award remains unvested with respect to the Corresponding Shares.

4. Vesting. Notwithstanding anything to the contrary herein or in the Plan, the Company will make no distributions with respect to Dividend Equivalents unless and until such Dividend Equivalents will have become vested. Dividend Equivalents will vest on the dates the Corresponding Shares under the Corresponding Awards (if any) are delivered to the Eligible Person (each, a “Vesting Date”).

---

 

5. Distributions.

 

 

 

6. Expiration. Unless earlier terminated in accordance with the terms and provisions of the Plan or this Agreement, a Dividend Equivalent will expire and be cancelled immediately following the earlier of (a) vesting (and cash distribution associated thereof in accordance with Section 5) of the Dividend Equivalent or (b) forfeiture or cancellation of the Corresponding Award.

* * * * *

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

 

 

COMPANY ELIGIBLE PERSON

Smith & Wesson Brands, Inc.

By: ____________________ By: ____________________

Name: ____________________ Name: ____________________

Title: ____________________ Title: ____________________

 

---

EXHIBIT A

 

 

 

---

 

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark P. Smith, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Smith & Wesson Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By:		/s/ Mark P. Smith
		Mark P. Smith
		President and Chief Executive Officer

Date: December 7, 2023

 

---

 

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Deana L. McPherson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Smith & Wesson Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:		/s/ Deana L. McPherson
		Deana L. McPherson
		Executive Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary

Date: December 7, 2023

 

---

 

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Smith & Wesson Brands, Inc. (the “Company”) for the quarterly period ended October 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark P. Smith, President and Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:		/s/ Mark P. Smith
		Mark P. Smith
		President and Chief Executive Officer

Date: December 7, 2023

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Smith & Wesson Brands, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

 

---

 

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Smith & Wesson Brands, Inc. (the “Company”) for the quarterly period ended October 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Deana L. McPherson, Executive Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:		/s/ Deana L. McPherson
		Deana L. McPherson
		Executive Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary

Date: December 7, 2023

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Smith & Wesson Brands, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

 

 

---

v3.23.3

Document and Entity Information - shares	6 Months Ended
	Oct. 31, 2023	Dec. 05, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 31, 2023
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Registrant Name	Smith & Wesson Brands, Inc.
Entity Central Index Key	0001092796
Current Fiscal Year End Date	--04-30
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	001-31552
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	87-0543688
Entity Address, Address Line One	2100 Roosevelt Avenue
Entity Address, City or Town	Springfield
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01104
City Area Code	800
Local Phone Number	331-0852
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		45,639,351
Title of each Class	Common Stock, par value $0.001 per share
Trading Symbol	SWBI
Name of exchange on which registered	NASDAQ

v3.23.3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Current assets:
Cash and cash equivalents	$ 44,192	$ 53,556
Accounts receivable, net of allowances for credit losses of $22 on October 31, 2023 and $23 on April 30, 2023	59,773	55,153
Inventories	163,291	177,118
Prepaid expenses and other current assets	9,870	4,917
Income tax receivable	4,713	1,176
Total current assets	281,839	291,920
Property, plant, and equipment, net	253,253	210,330
Intangibles, net	2,823	3,588
Goodwill	19,024	19,024
Deferred income taxes	8,085	8,085
Other assets	7,949	8,347
Total assets	572,973	541,294
Current liabilities:
Accounts payable	44,536	36,795
Accrued expenses and deferred revenue	23,197	20,149
Accrued payroll and incentives	19,889	18,565
Accrued income taxes	190	1,831
Accrued profit sharing	1,504	8,203
Accrued warranty	1,578	1,670
Total current liabilities	90,894	87,213
Notes and loans payable (Note 4)	64,836	24,790
Finance lease payable, net of current portion	36,209	36,961
Other non-current liabilities	7,532	7,707
Total liabilities	199,471	156,671
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized, no shares issued or outstanding	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 75,322,622 issued and 45,636,482 shares outstanding on October 31, 2023 and 75,029,300 shares issued and 45,988,930 shares outstanding on April 30, 2023	75	75
Additional paid-in capital	286,341	283,666
Retained earnings	517,682	523,184
Accumulated other comprehensive income	73	73
Treasury stock, at cost (29,686,140 shares on October 31, 2023 and 29,040,370 on April 30, 2023)	(430,669)	(422,375)
Total stockholders’ equity	373,502	384,623
Total liabilities and stockholders' equity	$ 572,973	$ 541,294

v3.23.3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Statement of Financial Position [Abstract]
Allowances for credit losses	$ 22	$ 23
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	75,322,622	75,029,300
Common stock, shares outstanding	45,636,482	45,988,930
Treasury Stock, Common, Shares	29,686,140	29,040,370

v3.23.3

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement [Abstract]
Net sales	$ 124,958	$ 121,035	$ 239,201	$ 205,429
Cost of sales	93,192	81,773	177,034	134,696
Gross profit	31,766	39,262	62,167	70,733
Operating expenses:
Research and development	1,724	1,869	3,522	3,542
Selling, marketing, and distribution	10,952	9,431	20,993	17,458
General and administrative	15,322	15,435	29,536	33,288
Total operating expenses	27,998	26,735	54,051	54,288
Operating income	3,768	12,527	8,116	16,445
Other income/(expense), net:
Other income/(expense), net	141	790	188	1,463
Interest (expense)/income, net	(646)	(420)	(492)	(854)
Total other (expense)/income, net	(505)	370	(304)	609
Income from operations before income taxes	3,263	12,897	7,812	17,054
Income tax expense	765	3,249	2,196	4,094
Net income	$ 2,498	$ 9,648	$ 5,616	$ 12,960
Net income per share:
Basic - net income	$ 0.05	$ 0.21	$ 0.12	$ 0.28
Diluted - net income	$ 0.05	$ 0.21	$ 0.12	$ 0.28
Weighted average number of common shares outstanding:
Basic	45,977	45,815	46,042	45,777
Diluted	46,361	46,106	46,458	46,104

v3.23.3

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive (Loss)/Income	Treasury Stock
Balance at Apr. 30, 2022	$ 360,514	$ 75	$ 278,101	$ 504,640	$ 73	$ (422,375)
Balance (in shares) at Apr. 30, 2022		74,641,000
Treasury stock (in shares) at Apr. 30, 2022						29,040,000
Stock-based compensation	2,605		2,605
Shares issued under employee stock purchase plan	753		753
Shares issued under employee stock purchase plan (in shares)		85,000
Issuance of common stock under restricted stock unit awards, net of shares surrendered	(1,039)		(1,039)
Issuance of common stock under restricted stock unit awards, net of shares surrendered (in shares)		209,000
Dividends issued	(9,153)			(9,153)
Net income	12,960			12,960
Balance at Oct. 31, 2022	366,640	$ 75	280,420	508,447	73	$ (422,375)
Balance (in shares) at Oct. 31, 2022		74,935,000
Treasury stock (in shares) at Oct. 31, 2022						29,040,000
Balance at Jul. 31, 2022	359,446	$ 75	278,297	503,376	73	$ (422,375)
Balance (in shares) at Jul. 31, 2022		74,811,000
Treasury stock (in shares) at Jul. 31, 2022						29,040,000
Stock-based compensation	1,428		1,428
Shares issued under employee stock purchase plan	753		753
Shares issued under employee stock purchase plan (in shares)		85,000
Issuance of common stock under restricted stock unit awards, net of shares surrendered	(58)		(58)
Issuance of common stock under restricted stock unit awards, net of shares surrendered (in shares)		39,000
Dividends issued	(4,577)			(4,577)
Net income	9,648			9,648
Balance at Oct. 31, 2022	366,640	$ 75	280,420	508,447	73	$ (422,375)
Balance (in shares) at Oct. 31, 2022		74,935,000
Treasury stock (in shares) at Oct. 31, 2022						29,040,000
Balance at Apr. 30, 2023	$ 384,623	$ 75	283,666	523,184	73	$ (422,375)
Balance (in shares) at Apr. 30, 2023	45,988,930	75,029,000
Treasury stock (in shares) at Apr. 30, 2023	29,040,370					29,040,000
Stock-based compensation	$ 2,759		2,759
Shares issued under employee stock purchase plan	722		722
Shares issued under employee stock purchase plan (in shares)		83,000
Issuance of common stock under restricted stock unit awards, net of shares surrendered	(806)		(806)
Issuance of common stock under restricted stock unit awards, net of shares surrendered (in shares)		211,000
Repurchase of treasury stock	(8,294)					$ 8,294
Repurchase of treasury stock, shares						(646,000)
Dividends issued	(11,080)			(11,080)
Unpaid dividends accrued	(38)			(38)
Net income	5,616			5,616
Balance at Oct. 31, 2023	$ 373,502	$ 75	286,341	517,682	73	$ (430,669)
Balance (in shares) at Oct. 31, 2023	45,636,482	75,323,000
Treasury stock (in shares) at Oct. 31, 2023	29,686,140					29,686,000
Balance at Jul. 31, 2023	$ 382,715	$ 75	284,176	520,766	73	$ (422,375)
Balance (in shares) at Jul. 31, 2023		75,184,000
Treasury stock (in shares) at Jul. 31, 2023						29,040,000
Stock-based compensation	1,484		1,484
Shares issued under employee stock purchase plan	722		722
Shares issued under employee stock purchase plan (in shares)		83,000
Issuance of common stock under restricted stock unit awards, net of shares surrendered	(41)		(41)
Issuance of common stock under restricted stock unit awards, net of shares surrendered (in shares)		56,000
Repurchase of treasury stock	(8,294)					$ 8,294
Repurchase of treasury stock, shares						(646,000)
Dividends issued	(5,544)			(5,544)
Unpaid dividends accrued	(38)			(38)
Net income	2,498			2,498
Balance at Oct. 31, 2023	$ 373,502	$ 75	$ 286,341	$ 517,682	$ 73	$ (430,669)
Balance (in shares) at Oct. 31, 2023	45,636,482	75,323,000
Treasury stock (in shares) at Oct. 31, 2023	29,686,140					29,686,000

v3.23.3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities:
Net income	$ 5,616	$ 12,960
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Depreciation and amortization	17,327	15,171
Loss/(gain) on sale/disposition of assets	682	(43)
Provision for recoveries on notes and accounts receivable	(1)	(13)
Stock-based compensation expense	2,759	2,605
Changes in operating assets and liabilities:
Accounts receivable	(4,619)	18,324
Inventories	13,827	(59,814)
Prepaid expenses and other current assets	(4,953)	(2,493)
Income taxes	(5,178)	(11,555)
Accounts payable	14,682	5,889
Accrued payroll and incentives	1,324	(329)
Accrued profit sharing	(6,699)	(7,915)
Accrued expenses and deferred revenue	2,859	307
Accrued warranty	(92)	(130)
Other assets	397	521
Other non-current liabilities	(175)	(1,650)
Net cash provided by/(used in) operating activities	37,756	(28,165)
Cash flows from investing activities:
Payments to acquire patents and software	(125)	(256)
Proceeds from sale of property and equipment	45	85
Payments to acquire property and equipment	(66,983)	(39,419)
Net cash used in investing activities	(67,063)	(39,590)
Cash flows from financing activities:
Proceeds from loans and notes payable	50,000	0
Payments on notes and loans payable	(10,000)	0
Payments on finance lease obligation	(681)	(559)
Payments to acquire treasury stock	(8,212)	0
Dividend distribution	(11,080)	(9,153)
Proceeds to acquire common stock from employee stock purchase plan	722	753
Payment of employee withholding tax related to restricted stock units	(806)	(1,039)
Net cash provided by/(used in) financing activities	19,943	(9,998)
Net decrease in cash and cash equivalents	(9,364)	(77,753)
Cash and cash equivalents, beginning of period	53,556	120,728
Cash and cash equivalents, end of period	44,192	42,975
Supplemental disclosure of cash flow information Cash paid for:
Interest, net of amounts capitalized	1,725	1,089
Income taxes	7,353	15,721
Supplemental Disclosure of Non-cash Investing Activities:
Purchases of property and equipment included in accounts payable	8,826	9,655
Capital lease included in accrued expenses and finance lease payable	$ 694	$ 0

v3.23.3

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 2,498	$ 9,648	$ 5,616	$ 12,960

v3.23.3

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.23.3

Organization	6 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	(1) Organization: We are one of the world’s leading manufacturers and designers of firearms. We manufacture a wide array of handguns (including revolvers and pistols), long guns (including modern sporting rifles), handcuffs, firearm suppressors, and other firearm-related products for sale to a wide variety of customers, including firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement and security agencies and officers, and military agencies in the United States and throughout the world. We sell our products under the Smith & Wesson and Gemtech brands. We manufacture our products at our facilities in Springfield, Massachusetts; Houlton, Maine; Deep River, Connecticut; and Maryville, Tennessee. We also sell our manufacturing services to other businesses to attempt to level-load our factories. We sell those services under our Smith & Wesson and Smith & Wesson Precision Components brands. During the quarter ended October 31, 2023, we began manufacturing and distribution activities from our new Maryville, Tennessee facility. See Note 9 — Commitments and Contingencies and Note 10 — Restructuring for more information regarding this plan.

v3.23.3

Basis of Presentation	6 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	(2) Basis of Presentation: Interim Financial Information – The condensed consolidated balance sheet as of October 31, 2023, the condensed consolidated statements of income for the three and six months ended October 31, 2023 and 2022, the condensed consolidated statements of changes in stockholders’ equity for the three and six months ended October 31, 2023 and 2022, and the condensed consolidated statements of cash flows for the six months ended October 31, 2023 and 2022 have been prepared by us without audit. In our opinion, all adjustments, which include only normal recurring adjustments necessary to fairly present the financial position, results of operations, changes in stockholders’ equity, and cash flows for the three and six months ended October 31, 2023 and for the periods presented, have been included. All intercompany transactions have been eliminated in consolidation. The consolidated balance sheet as of April 30, 2023 has been derived from our audited consolidated financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Fiscal 2023 Form 10-K. The results of operations for the three and six months ended October 31, 2023 may not be indicative of the results that may be expected for the fiscal year ending April 30, 2024, or any other period.

v3.23.3

Leases	6 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Leases	(3) Leases: We lease certain of our real estate, machinery, equipment, and photocopiers under non-cancelable operating and finance lease agreements. We recognize expenses for our operating lease assets and liabilities at the commencement date based on the present value of lease payments over the lease term. Our leases do not provide an implicit interest rate. We use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Our lease agreements do not require material variable lease payments or residual value guarantees, nor do they include restrictive covenants. For operating leases, we recognize expense on a straight-line basis over the lease term. Tenant improvement allowances are recorded as an offsetting adjustment included in our calculation of the respective right-of-use asset. Many of our leases include renewal options that enable us to extend the lease term. The execution of those renewal options is at our sole discretion and renewals are reflected in the lease term when they are reasonably certain to be exercised. The depreciable life of assets and leasehold improvements are limited by the expected lease term. The amounts of assets and liabilities related to our operating and financing leases as of October 31, 2023 were as follows (in thousands):       Balance Sheet Caption   October 31, 2023   Operating Leases           Right-of-use assets       $ 5,994   Accumulated amortization         (4,787 ) Right-of-use assets, net   Other assets   $ 1,207               Current liabilities   Accrued expenses and deferred revenue   $ 727   Non-current liabilities   Other non-current liabilities     678   Total operating lease liabilities       $ 1,405   Finance Leases           Right-of-use assets       $ 41,631   Accumulated depreciation         (10,580 ) Right-of-use assets, net   Property, plant, and equipment, net   $ 31,051               Current liabilities   Accrued expenses and deferred revenue   $ 1,498   Non-current liabilities   Finance lease payable, net of current portion     36,209   Total finance lease liabilities       $ 37,707   During the three months ended October 31, 2023, we recorded $411,000 of operating lease costs, of which $41,000 related to short-term leases that were not recorded as right-of-use assets. We recorded $566,000 of finance lease amortization and $475,000 of financing lease interest expense for the three months ended October 31, 2023. As of October 31, 2023, the weighted average lease term and weighted average discount rate for our operating leases was 2.8 years and 4.4%, respectively. As of October 31, 2023, the weighted average lease term and weighted average discount rate for our financing leases were 14.8 years and 5.0%, respectively, and consisted primarily of our Missouri facility. The building is pledged to secure the amounts outstanding. The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight-line basis over the life of the lease. On October 26, 2017, we entered into (a) a lease agreement with Ryan Boone County, LLC, or the Original Missouri Landlord, concerning certain real property located in Boone County, Missouri on which we had, until recently, been operating a distribution center, or the Missouri Lease, and (b) a guaranty in favor of the Original Missouri Landlord, or the Guaranty. With the completion of the spin-off of our outdoor products and accessories business on August 24, 2020, or the Separation, we entered into a sublease whereby American Outdoor Brands, Inc., our former wholly owned subsidiary, or AOUT, subleases from us 59.0% of our Missouri distribution center under the same terms as the Missouri Lease, or the Missouri Sublease. On July 16, 2022, we entered into an amendment to the Missouri Sublease, increasing the leased space to 64.7% of the facility under the same terms as the Missouri Lease. On January 31, 2023, we entered into (i) an assignment and assumption agreement with AOUT, pursuant to which AOUT will assume all of our rights, entitlement, and obligations in, to, and under the Missouri Lease, in each case effective on January 1, 2024, subject to a number of conditions precedent, or the Assignment and Assumption Agreement, and (ii) an amended and restated guaranty in favor of RCS-S&W Facility, LLC, as successor in interest to the Original Missouri Landlord, pursuant to which Smith & Wesson Sales Company was added as a guarantor, or the Amended and Restated Guaranty. We intend to terminate the Missouri Sublease on or around the effective date of the Assignment and Assumption Agreement. As of October 31, 2023, income related to the Missouri Sublease was $1.3 million, of which $722,000 was recorded in general and administrative expenses and $581,000 was recorded in interest expense, net, in our condensed consolidated statements of income. In addition, we intend to occupy our Connecticut facility at least through May 4, 2024, the end of the current lease term and may seek to extend the lease through the end of calendar 2024. We do not currently believe there are any indications of impairment relating to these right-of-use assets. The following table represents future expected undiscounted cashflows, based on the sublease agreement with AOUT, to be received on an annual basis for the next five years and thereafter, as of October 31, 2023 (in thousands):   Fiscal   Amount   2024   $ 1,399   2025     3,180   2026     3,235   2027     3,292   2028     3,350   Thereafter     38,906   Total future sublease receipts     53,362   Less amounts representing interest     (16,408 ) Present value of sublease receipts   $ 36,954   Future lease payments for all our operating and finance leases for succeeding fiscal years is as follows (in thousands):       Operating     Financing     Total   2024       $ 650     $ 1,675     $ 2,325   2025         324       3,378       3,702   2026         301       3,433       3,734   2027         272       3,490       3,762   2028         125       3,424       3,549   Thereafter         —       38,906       38,906   Total future lease payments         1,672       54,306       55,978   Less amounts representing interest         (267 )     (16,599 )     (16,866 ) Present value of lease payments         1,405       37,707       39,112   Less current maturities of lease liabilities         (727 )     (1,498 )     (2,225 ) Long-term maturities of lease liabilities       $ 678     $ 36,209     $ 36,887     During the three and six months ended October 31, 2023, the cash paid for amounts included in the measurement of liabilities and operating cash flows was $1.2 million and $2.3 million, respectively.

v3.23.3

Notes, Loans Payable, and Financing Arrangements	6 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Notes, Loans Payable, and Financing Arrangements	(4) Notes, Loans Payable, and Financing Arrangements: Credit Facilities — On August 24, 2020, we and certain of our subsidiaries entered into an amended and restated credit agreement, or the Amended and Restated Credit Agreement, with certain lenders, including TD Bank, N.A., as administrative agent; TD Securities (USA) LLC, and Regions Bank, as joint lead arrangers and joint bookrunners; and Regions Bank, as syndication agent. The Amended and Restated Credit Agreement is currently unsecured; however, should any Springing Lien Trigger Event (as defined in the Amended and Restated Credit Agreement) occur, we and certain of our subsidiaries would be required to execute certain documents in favor of TD Bank, N.A., as administrative agent, and the lenders party to such documents would have a legal, valid, and enforceable ‎first priority lien on the collateral described therein. The Amended and Restated Credit Agreement provides for a revolving line of credit of $100.0 million at any one time, or the Revolving Line. The Revolving Line bears interest at either the Base Rate (as defined in the Amended and Restated Credit Agreement) or the SOFR rate, plus an applicable margin based on our consolidated leverage ratio. The Amended and Restated Credit Agreement also provides a swingline facility in the maximum amount of $5.0 million at any one time (subject to availability under the Revolving Line). Each Swingline Loan (as defined in the Amended and Restated Credit Agreement) bears interest at the Base Rate, plus an applicable margin based on our Adjusted Consolidated Leverage Ratio (as defined in the Amended and Restated Credit Agreement). Subject to the satisfaction of certain terms and conditions described in the Amended and Restated Credit Agreement, we have an option to increase the Revolving Line by an aggregate amount not exceeding $50.0 million. The Revolving Line matures on the earlier of August 24, 2025 or the date that is six months in advance of the earliest maturity of any Permitted Notes (as defined in the Amended and Restated Credit Agreement) under the Amended and Restated Credit Agreement. On April 28, 2023, we entered into an amendment to our existing credit agreement to, among other things, replace LIBOR with SOFR as the interest rate benchmark and amend the definition of “Consolidated Fixed Charge Coverage Ratio” to exclude unfinanced capital expenditures in connection with the Relocation. As of October 31, 2023, we had $65.0 million of borrowings outstanding on the Revolving Line, bearing interest at an average rate of 7.17%, which is equal to the SOFR rate plus an applicable margin. As a result of the construction associated with the Relocation, $665,000 of interest has been capitalized for the six months ended October 31, 2023. The Amended and Restated Credit Agreement contains customary limitations, including limitations on indebtedness, liens, fundamental changes to business or organizational structure, investments, loans, advances, guarantees, and acquisitions, asset sales, dividends, stock repurchases, stock redemptions, and the redemption or prepayment of other debt, and transactions with affiliates. We are also subject to financial covenants, including a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio. As of October 31, 2023, we were compliant with all required financial covenants. Letters of Credit — At October 31, 2023, we had outstanding letters of credit aggregating $2.7 million, which included a $1.5 million letter of credit to collateralize our captive insurance company.

v3.23.3

Fair Value Measurement	6 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement	(5) Fair Value Measurement: We follow the provisions of Accounting Standards Codification, or ASC, 820-10, Fair Value Measurements and Disclosures Topic, or ASC 820-10, for our financial assets and liabilities. ASC 820-10 provides a framework for measuring fair value under GAAP and requires expanded disclosures regarding fair value measurements. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. Financial assets and liabilities recorded on the accompanying condensed consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows: Level 1 — Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that we have the ability to access at the measurement date (e.g., active exchange-traded equity securities, listed derivatives, and most U.S. Government and agency securities). Our cash and cash equivalents, which are measured at fair value on a recurring basis, totaled $44.2 million and $53.6 million as of October 31, 2023 and April 30, 2023, respectively. The carrying value of our revolving line of credit approximated the fair value as of October 31, 2023. We utilized Level 1 of the value hierarchy to determine the fair values of these assets. Level 2 — Financial assets and liabilities whose values are based on quoted prices in markets in which trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets. Level 2 inputs include the following: • quoted prices for identical or similar assets or liabilities in non-active markets (such as corporate and municipal bonds which trade infrequently); • inputs other than quoted prices that are observable for substantially the full term of the asset or liability (such as interest rate and currency swaps); and • inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (such as certain securities and derivatives). Level 3 — Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect our judgments about the assumptions a market participant would use in pricing the asset or liability. We did not have any Level 2 or Level 3 financial assets or liabilities as of October 31, 2023.

v3.23.3

Inventories	6 Months Ended
	Oct. 31, 2023
Inventory Disclosure [Abstract]
Inventories	(6) Inventories: The following table sets forth a summary of inventories, net of reserves, stated at lower of cost or net realizable value, as of October 31, 2023 and April 30, 2023 (in thousands):       October 31, 2023     April 30, 2023   Finished goods   $ 95,646     $ 93,705   Finished parts     47,980       65,460   Work in process     7,026       6,821   Raw material     12,639       11,132   Total inventories   $ 163,291     $ 177,118

v3.23.3

Accrued Expenses and Deferred Revenue	6 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Deferred Revenue	(7) Accrued Expenses and Deferred Revenue: The following table sets forth other accrued expenses as of October 31, 2023 and April 30, 2023 (in thousands):   October 31, 2023     April 30, 2023   Accrued taxes other than income   $ 5,250     $ 3,703   Accrued employee benefits     3,339       3,256   Accrued settlement     3,200       —   Accrued distributor incentives     2,931       1,640   Accrued other     2,494       4,597   Accrued professional fees     2,145       2,596   Accrued rebates and promotions     1,613       1,649   Current portion of finance lease obligation     1,498       1,434   Current portion of operating lease obligation     727       1,274   Total accrued expenses and deferred revenue   $ 23,197     $ 20,149

v3.23.3

Stockholders' Equity	6 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Stockholders' Equity	(8) Stockholders’ Equity: Treasury Stock On September 19, 2023, our Board of Directors authorized the repurchase of up to $50.0 million of our common stock, subject to certain conditions, in the open market or in privately negotiated transactions. Through the three months ended October 31, 2023, we repurchased 645,770 shares of our common stock for $8.2 million under this authorization. There were no common stock purchases through the six months ended October 31, 2022, nor were there any unfulfilled authorizations. Earnings per Share The following table provides a reconciliation of the net income amounts and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the three months ended October 31, 2023 and 2022 (in thousands, except per share data):   For the Three Months Ended October 31,     2023     2022     Net           Per Share     Net           Per Share     Income     Shares     Amount     Income     Shares     Amount   Basic earnings $   2,498       45,977     $   0.05     $   9,648       45,815     $   0.21   Effect of dilutive stock awards   —       384       —       —       291       —   Diluted earnings $   2,498       46,361     $   0.05     $   9,648       46,106     $   0.21     The following table provides a reconciliation of the net income amounts and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the six months ended October 31, 2023 and 2022 (in thousands, except per share data):   For the Six Months Ended October 31,     2023     2022     Net           Per Share     Net           Per Share     Income     Shares     Amount     Income     Shares     Amount   Basic earnings $   5,616       46,042     $   0.12     $   12,960       45,777     $   0.28   Effect of dilutive stock awards   —     416       —       —       327       —   Diluted earnings $   5,616       46,458     $   0.12     $   12,960       46,104     $   0.28   For the three months ended October 31, 2023 and 2022, the amount of restricted stock units, or RSUs, excluded from the computation of diluted earnings per share was 15,719 and 23,264, respectively, because the effect would be antidilutive. For the six months ended October 31, 2023 and 2022, the amount of shares excluded from the computation of diluted earnings per share was 18,028 and 25,730, respectively, because the effect would be antidilutive. Incentive Stock and Employee Stock Purchase Plans In September 2022, our stockholders approved the 2022 Incentive Stock Plan under which employees and non-employees may be granted stock options, restricted stock awards, restricted stock units, stock appreciation rights, bonus stock and awards in lieu of obligations, performance awards, and dividend equivalents. We have an Employee Stock Purchase Plan, or the ESPP, under which each participant is granted an option to purchase our common stock at a discount on each subsequent exercise date during the offering period (as such terms are defined in the ESPP) in accordance with the terms of the ESPP. The total stock-based compensation expense, including stock options, purchases under our ESPP, RSUs, and performance-based RSUs, or PSUs, was $2.8 million and $2.6 million for the six months ended October 31, 2023 and 2022, respectively. We include stock-based compensation expense in cost of sales, sales, marketing, and distribution, research and development, and general and administrative expenses. We grant RSUs to employees and non-employee members of our Board of Directors. The awards are made at no cost to the recipient. An RSU represents the right to receive one share of our common stock and does not carry voting or dividend rights. Except in specific circumstances, RSU grants to employees vest over a period of four years with one-fourth of the units vesting on each anniversary of the grant date. We amortize the aggregate fair value of our RSU grants to compensation expense over the vesting period. We grant PSUs to our executive officers and, from time to time, certain management employees who are not executive officers. The PSUs vest, and the fair value of such PSUs will be recognized, over the corresponding three-year performance period. During the six months ended October 31, 2023, we granted an aggregate of 357,357 RSUs, including 180,814 RSUs to non-executive officer employees, 117,724 RSUs to our executive officers, and 58,819 RSUs to our directors. During the six months ended October 31, 2023, we granted 176,583 PSUs to certain of our executive officers. During the six months ended October 31, 2023, we cancelled 158,100 PSUs as a result of the failure to satisfy the performance metric and 13,287 RSUs as a result of the service conditions not being met. In connection with the vesting of RSUs, during the six months ended October 31, 2023, we delivered common stock to our employees, former employees, and directors, including our executive officers, with a total market value of $6.5 million. In connection with a 2019 grant, which vested in fiscal 2023, we delivered market-condition PSUs to certain of our executive officers and a former executive officer with a total market value of $664,000.   During the six months ended October 31, 2022, we granted an aggregate of 286,218 RSUs, including 157,227 RSUs to non-executive officer employees, 72,494 RSUs to our executive officers, and 56,497 RSUs to our directors. During the six months ended October 31, 2022, we granted 108,736 PSUs to certain of our executive officers. During the six months ended October 31, 2022, we cancelled 3,996 RSUs as a result of the service conditions not being met. In connection with the vesting of RSUs, during the six months ended October 31, 2022, we delivered common stock to our employees, former employees, and directors, including our executive officers, with a total market value of $3.9 million. In connection with a 2018 grant, which vested in fiscal 2022, we delivered market-condition PSUs to certain of our executive officers and a former executive officer with a total market value of $1.2 million. In addition, in connection with a 2019 grant, 57,600 PSUs vested to certain of our executive officers and a former executive officer, which resulted from achieving the maximum performance of 200.0% of target for the original 28,800 PSUs granted. A summary of activity for unvested RSUs and PSUs for the six months ended October 31, 2023 and 2022 is as follows:     For the Six Months Ended October 31,       2023     2022             Weighted           Weighted       Total # of     Average     Total # of     Average       Restricted     Grant Date     Restricted     Grant Date       Stock Units     Fair Value     Stock Units     Fair Value   RSUs and PSUs outstanding, beginning of period     932,705     $ 13.14       827,930     $ 13.30   Awarded     533,940       12.07       423,754   (a)   13.53   Released     (276,977 )     11.43       (281,135 )     13.88   Forfeited     (171,387 )     10.69       (3,996 )     15.23   RSUs and PSUs outstanding, end of period     1,018,281     $ 13.47       966,553     $ 13.23     (a) Includes 43,200 PSUs vested during the six months ended October 31, 2023, in connection with achieving maximum performance targets for the 2019. As of October 31, 2023, there was $6.0 million of unrecognized compensation expense related to unvested RSUs and PSUs. This expense is expected to be recognized over a weighted average remaining contractual term of 1.7 years.

v3.23.3

Commitments and Contingencies	6 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	(9) Commitments and Contingencies: Litigation In January 2018, Gemini Technologies, Incorporated, or Gemini, commenced an action against us in the U.S. District Court for the District of Idaho, or the District Court. The complaint alleges, among other things, that we breached the earn-out and other provisions of the asset purchase agreement and ancillary agreements between the parties in connection with our acquisition of the Gemtech business from Gemini. The complaint seeks a declaratory judgment interpreting various terms of the asset purchase agreement and damages in the sum of $18.6 million. In May 2018, the District Court dismissed the complaint on the grounds of forum non conveniens. In June 2018, Gemini appealed that decision to the U.S. Court of Appeals for the Ninth Circuit, or the Ninth Circuit. In July 2019, the Ninth Circuit reversed the dismissal and remanded the case to the District Court to perform a traditional forum non conveniens analysis. In September 2019, the parties stipulated that they do not contest that the venue is proper in the District of Idaho. In November 2019, we filed an answer to Gemini’s complaint and a counterclaim against Gemini and its stockholders at the time of the signing of the asset purchase agreement. Plaintiffs amended their complaint to add a claim of fraud in the inducement. In September 2021, Gemini filed a motion for summary judgment seeking to dismiss our counterclaim. In June 2022, the court denied Gemini's motion for summary judgment. Gemini filed a second motion for summary judgment, and on August 14, 2023, the court again denied Gemini’s motion. On November 22, 2023, we entered into a settlement agreement with plaintiffs on the indemnity and counterclaims. On the same day, plaintiffs filed a motion for leave, seeking to file a second amended complaint. We believe the remaining claims asserted in the complaint have no merit, and we intend to aggressively defend this action. We are a defendant in five product liability cases and are aware of five other product liability claims, primarily alleging defective product design, defective manufacturing, or failure to provide adequate warnings. In addition, we are a co-defendant in a case filed in August 1999 by the city of Gary, Indiana, or the City, against numerous firearm manufacturers, distributors, and dealers seeking to recover monetary damages, as well as injunctive relief, allegedly arising out of the misuse of firearms by third parties. In January 2018, the Lake Superior Court, County of Lake, Indiana granted defendants’ Motion for Judgment on the Pleadings, dismissing the case in its entirety. In February 2018, plaintiffs appealed the dismissal to the Indiana Court of Appeals. In May 2019, the Indiana Court of Appeals issued a decision, which affirmed in part and reversed in part, and remanded for further proceedings, the trial court’s dismissal of the City’s complaint. In July 2019, defendants filed a Petition to Transfer jurisdiction to the Indiana Supreme Court. In November 2019, the Indiana Supreme Court denied defendants' petition to transfer, and the case was returned to the trial court. Discovery remains ongoing. We are a defendant in a putative class proceeding before the Ontario Superior Court of Justice in Toronto, Canada that was filed in December 2019. The action claims CAD$50 million in aggregate general damages, CAD$100 million in aggregate punitive damages, special damages in an unspecified amount, together with interest and legal costs. The named plaintiffs are two victims of a shooting that took place in Toronto in July 2018 and their family members. One victim was shot and injured during the shooting. The other victim suffered unspecified injuries while fleeing the shooting. The plaintiffs are seeking to certify a claim on behalf of classes that include all persons who were killed or injured in the shooting and their immediate family members. The plaintiffs allege negligent design and public nuisance. The case has not been certified as a class action. In July 2020, we filed a Notice of Motion for an order striking the claim and dismissing the action in its entirety. In February 2021, the court granted our motion in part, and dismissed the plaintiffs’ claims in public nuisance and strict liability. The court declined to strike the negligent design claim and ordered that the claim proceed to a certification motion. In March 2021, we filed a motion for leave to appeal the court’s refusal to strike the negligent design claim with the Divisional Court, Ontario Superior Court of Justice. In July 2021, plaintiffs filed a motion to stay our motion for leave to appeal with the Divisional Court, on grounds that appeal is premature. In November 2021, the Divisional Court granted plaintiffs' motion, staying our motion for leave to appeal until 30 days after the decision on the balance of plaintiffs' certification motion. Plaintiffs’ certification motion has been extended by the court to January 2024. In May 2020, we were named in an action related to the Chabad of Poway synagogue shooting that took place in April 2019. The complaint was filed in the Superior Court of the State of California, for the County of San Diego – Central, and asserts claims against us for product liability, unfair competition, negligence, and public nuisance. The plaintiffs allege they were present at the synagogue on the day of the incident and suffered physical and/or emotional injury. The plaintiffs seek compensatory and punitive damages, attorneys’ fees, and injunctive relief. In September 2020, we filed a demurrer and motion to strike, seeking to dismiss plaintiffs’ complaint. In July 2021, the court granted our motion in part, and reversed it in part, ruling that (1) the PLCAA barred plaintiffs’ product liability action; (2) plaintiffs did not have standing to maintain an action under the Unfair Competition Law for personal injury related damages, but gave plaintiffs leave to amend to plead an economic injury; and (3) the PLCAA did not bar plaintiffs’ ordinary negligence and public nuisance actions because plaintiffs had alleged that we violated 18 U.S.C. Section 922(b)(4), which generally prohibits the sale of fully automatic “machineguns.” In August 2021, we filed a Petition for Writ of Mandate in the Court of Appeal of the State of California, Fourth Appellate District, Division One. In September 2021, the Court of Appeal denied our appeal. In February 2022, the court consolidated the case with three related cases, in which we are not a party. In March 2022, the court granted our motion, dismissing plaintiffs’ Unfair Competition Law claim, without further leave to amend. Discovery is ongoing. On February 28, 2023, we filed a motion for summary judgment. On May 19, 2023, the court denied our motion for summary judgment without prejudice and allowed plaintiffs time for additional, limited discovery. A hearing on our renewed motion for summary judgment is scheduled for January 12, 2024, and the trial date has been moved to August 30, 2024. We are a defendant in an action filed in the U.S. District Court for the District of Massachusetts. In August 2021, the Mexican Government filed an action against several U.S.-based firearms manufacturers and a firearms distributor, claiming defendants design, market, distribute, and sell firearms in ways they know routinely arm the drug cartels in Mexico. Plaintiff alleges, among other claims, negligence, public nuisance, design defect, unjust enrichment and restitution against all defendants and violation of the Massachusetts Consumer Protection Act against us alone, and is seeking monetary damages and injunctive relief. In November 2021, defendants filed motions to dismiss plaintiff's complaint. In September 2022, the district court granted defendants’ motions to dismiss. In October 2022, plaintiff filed a notice of appeal with the U.S. Court of Appeals for the First Circuit. Oral argument concerning the appeal was held on July 24, 2023. No decision has issued to date. In September 2022, we were named as defendants in 12 nearly identical, separate actions related to a shooting in Highland Park, Illinois on July 4, 2022. The complaints were filed in the Circuit Court of the Nineteenth Judicial Circuit in Lake County, Illinois and assert claims against us for negligence and for deceptive and unfair practices under the Illinois Consumer Fraud and Deceptive Business Practices Act. Plaintiffs also name as defendants the website and retailer that sold the firearm, the shooter, and the shooter’s father. The plaintiffs allege they were present at a parade at the time of the incident and suffered physical and/or emotional injury. The plaintiffs seek compensatory damages, attorneys’ fees, and injunctive relief. We filed motions for removal of each case to the U.S. District Court for the Northern District of Illinois. In November 2022, we filed a motion to consolidate the cases for preliminary motion purposes. In December 2022, plaintiffs filed motions to remand the cases back to the state court. On January 20, 2023, we filed our opposition to plaintiffs’ motion to remand. On September 25, 2023, the court granted plaintiffs’ motion to remand. On October 16, 2023, we filed a notice of appeal to the U.S. Court of Appeals for the Seventh Circuit. On October 20, 2023, we filed a Motion for Stay of the Remand Order with the U.S. District Court, seeking a stay of the remand, pending our appeal to the Seventh Circuit. On October 30, 2023, the court granted a stay of the remand pending appeal. On November 8, 2023, plaintiffs filed a motion to lift the stay pending appeal. No decision has been issued to date on plaintiffs’ motion. In December 2022, the City of Buffalo, New York filed a complaint in the Supreme Court of the State of New York, County of Erie, against numerous manufacturers, distributors, and retailers of firearms. Later in December 2022, the City of Rochester, New York filed an almost identical complaint in the Supreme Court of the State of New York, County of Monroe, against the same defendants. The complaints allege violation of New York General Business Law, public nuisance, and deceptive business practices in violation of NY General Business Laws. In January 2023, we filed notices of removal of the cases to the US District Court. On March 24, 2023, defendants filed a motion to stay both cases pending a ruling by the U.S. Court of Appeals for the Second Circuit in the NSSF v. James case. On June 8, 2023, the court granted defendants’ motions to consolidate and to stay pending resolution of the NSSF v. James appeal. We believe that the various allegations as described above are unfounded, and, in addition, that any incident and any results from them or any injuries were due to negligence or misuse of the firearm by the claimant or a third party. In March 2022, two plaintiffs, on behalf of a proposed class of current and former employees and temporary workers who worked at our Springfield facility from November 2018 to the present, filed a claim alleging non-payment of wages and overtime in violation of the Massachusetts Wage Act and Massachusetts Fair Wage Act. The case has not been certified as a class action. On September 21, 2023, the parties agreed to settle the matter, and are negotiating a formal settlement agreement, which will be subject to court approval. In addition, from time to time, we are involved in lawsuits, claims, investigations, and proceedings, including commercial, environmental, premises and employment matters, which arise in the ordinary course of business. The relief sought in individual cases primarily includes compensatory and, sometimes, punitive damages. Certain of the cases and claims seek unspecified compensatory or punitive damages. In others, compensatory damages sought may range from less than $75,000 to approximately $50.0 million. In our experience, initial demands do not generally bear a reasonable relationship to the facts and circumstances of a particular matter. We believe that our accruals for product liability cases and claims are a reasonable quantitative measure of the cost to us of product liability cases and claims. We are also involved in a putative stockholder derivative lawsuit filed on December 5, 2023 in the Eighth Judicial District Court, Clark County, Nevada. The action was brought by plaintiffs seeking to act on our behalf against our directors and certain of our executive officers. The complaint alleges breach of fiduciary duties by knowingly allowing us to become exposed to significant liability for intentionally violating federal, state, and local laws through our manufacturing, marketing, and sale of “AR-15 style rifles”. The derivative plaintiffs seek damages on our behalf from the individual defendants, as well as reforms and improvements to our compliance procedures and governance policies. We are vigorously defending ourselves in the lawsuits to which we are subject. An unfavorable outcome or prolonged litigation could harm our business. Litigation of this nature also is expensive, time consuming, and diverts the time and attention of our management. We monitor the status of known claims and the related product liability accrual, which includes amounts for defense costs for asserted and unasserted claims. After consultation with litigation counsel and a review of the merit of each claim, we have concluded that we are unable to reasonably estimate the probability or the estimated range of reasonably possible losses related to material adverse judgments related to such claims and, therefore, we have not accrued for any such judgments. In the future, should we determine that a loss (or an additional loss in excess of our accrual) is at least reasonably possible and material, we would then disclose an estimate of the possible loss or range of loss, if such estimate could be made, or disclose that an estimate could not be made. We believe that we have provided adequate accruals for defense costs. At this time, an estimated range of reasonably possible additional losses relating to unfavorable outcomes cannot be made. Commitments On September 30, 2021, we announced our plan to move our headquarters and significant elements of our operations to Maryville, Tennessee in 2023, or the Relocation. In connection with the Relocation, we entered into a project agreement, or the Project Agreement, with The Industrial Development Board of Blount County and the cities of Alcoa and Maryville, Tennessee, a public, nonprofit corporation organized and existing under the laws of the state of Tennessee, or the IDB. Pursuant to the Project Agreement, we represented to the IDB that we intend to incur, or cause to be incurred, no less than $120.0 million in aggregate capital expenditures on or before December 31, 2025, create no less than 620 new jobs, and sustain an average hourly wage of at least $25.97 at the facility. Further, pursuant to the Project Agreement, we are required to, among other things, (A) execute a facility lease and an equipment lease with the IDB; (B) cause the construction of the new facility at our sole cost and expense to commence on or before May 31, 2022; (C) incur, or cause to be incurred, aggregate capital expenditures in connection with the construction and equipping of the new facility in an aggregate amount of not less than $120.0 million on or before December 31, 2025; (D) cause the construction of the new facility to be substantially completed and for a certificate of occupancy to be issued therefore on or before December 31, 2023; (E) provide the IDB with a written report certified by one of our authorized officers, not later than January 31 of each year during the period between January 31, 2024 and January 31, 2031; and (F) make certain payments to IDB in the event that our actual capital expenditures, number of employees, or average hourly wage of such employees are less than our projections. On February 2, 2023, we entered into a design-build agreement with The Christman Company, or Christman, related to the construction of our new distribution center and corporate office headquarters in Maryville, or the Construction Contract. The Construction Contract has an effective date of September 13, 2021 and incorporates the arrangements under which we and Christman have been proceeding. Pursuant to the Construction Contract, Christman is obligated to deliver certain services, including, among others, design phase services and construction phase services, and we are obligated to pay Christman for services performed. The parties to the Construction Contract have jointly agreed that Christman will perform and complete the Work (as defined therein) on a cost-plus basis for a guaranteed maximum price of $114,533,853, including contingencies. When adding the cost of machinery and equipment, we expect to spend between $160.0 million and $170.0 million through the end of fiscal 2024. The Construction Contract includes terms that are customary for contracts of this type, including with respect to indemnification and insurance. The Construction Contract lists certain contract milestones and guaranteed completion dates, and we will be entitled to liquidated damages under certain circumstances. Each party to the Construction Contract is entitled to terminate the Construction Contract under certain circumstances. As part of the Relocation, on January 31, 2023, we entered into the Assignment and Assumption Agreement and the Amended and Restated Guaranty related to the Missouri facility. Assets associated with our distribution operations in Missouri were evaluated for cost recovery as we began the movement of inventory to the Tennessee facility during the fiscal quarter ended July 31, 2023. Consequently, as of October 31, 2023, we recorded an impairment of $1.9 million relating to equipment that we do not currently expect to utilize in the Tennessee facility nor to recover the net book value in a sale of the asset. Assets associated with certain of our assembly operations in Massachusetts continue to be fully utilized, and we intend to either move those assets to Tennessee at the appropriate time or sell or sublease those assets that will not be moved. Consequently, as of October 31, 2023, we do not believe we had an impairment related to the building or assets. Subsequent to the Relocation, we expect our Massachusetts facility will continue to remain an important part of our manufacturing activities with significant portions of the operations being unaffected by the Relocation. In addition, we intend to relocate a portion of our plastic injection molding operations to the Tennessee facility. The relocation of these assets began in our second quarter of 2023. We will evaluate selling the remaining molding operations utilized in our Connecticut facility to a third party. As of October 31, 2023, most of the plastic injection molding machinery and equipment was being utilized, had been relocated to the Tennessee facility, or had been disposed. We will continue to evaluate possible losses associated with any impairment of such assets as we determine which assets may be sold.

v3.23.3

Restructuring	6 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring	(10) Restructuring: As a result of the Relocation, $2.1 million and $3.1 million of restructuring charges were recorded in the three months ended October 31, 2023 and 2022, respectively, and $6.0 million and $5.3 million of restructuring charges were recorded in the six months ended October 31, 2023 and 2022, respectively. The following table summarizes restructuring charges by line item for the three and six months ended October 31, 2023 and 2022 (in thousands):       For the Three Months Ended October 31,     For the Six Months Ended October 31,       2023     2022     2023     2022   Cost of sales   $ 409     $ 1,735     $ 1,312     $ 2,978   Research and development     —       —       —       3   Selling, marketing, and distribution     774       270       2,969       707   General and administrative     878       1,106       1,692       1,620   Total restructuring charges   $ 2,061     $ 3,110     $ 5,973     $ 5,308     The components of the restructuring charges recorded in our condensed consolidated statements of income were as follows (in thousands):       For the Three Months Ended October 31,     For the Six Months Ended October 31,       2023     2022     2023     2022   Severance and employee-related benefits (a)   $ (49 )   $ 2,505     $ 881     $ 3,658   Relocation (a)     210       179       447       1,062   Public relations     922       —       922       —   Freight     199       —       199       —   Consulting services     246       206       456       266   Employee relations     469       135       926       230   Office rent and equipment     64       86       2,142       92   Total restructuring charges   $ 2,061     $ 3,110     $ 5,973     $ 5,308     a) Recorded in accrued payroll and incentives. The following table summarizes the activity in the severance and employee-related benefits and relocation accruals for the six months ended October 31, 2023 (in thousands):       Severance and employee-related benefits     Relocation     Total   Accrual at April 30, 2023   $ 10,054     $ 1,746     $ 11,800       Charges     881       447       1,328       Cash payments and settlements     (926 )     (1,395 )     (2,321 ) Accrual at October 31, 2023 (a)   $ 10,010     $ 798     $ 10,808     a) Recorded in accrued payroll and incentives.

v3.23.3

Basis of Presentation (Policies)	6 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Interim Financial Information	Interim Financial Information – The condensed consolidated balance sheet as of October 31, 2023, the condensed consolidated statements of income for the three and six months ended October 31, 2023 and 2022, the condensed consolidated statements of changes in stockholders’ equity for the three and six months ended October 31, 2023 and 2022, and the condensed consolidated statements of cash flows for the six months ended October 31, 2023 and 2022 have been prepared by us without audit. In our opinion, all adjustments, which include only normal recurring adjustments necessary to fairly present the financial position, results of operations, changes in stockholders’ equity, and cash flows for the three and six months ended October 31, 2023 and for the periods presented, have been included. All intercompany transactions have been eliminated in consolidation. The consolidated balance sheet as of April 30, 2023 has been derived from our audited consolidated financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Fiscal 2023 Form 10-K. The results of operations for the three and six months ended October 31, 2023 may not be indicative of the results that may be expected for the fiscal year ending April 30, 2024, or any other period.

v3.23.3

Leases (Tables)	6 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Assets and Liabilities Related to Operating and Financing Leases	The amounts of assets and liabilities related to our operating and financing leases as of October 31, 2023 were as follows (in thousands):       Balance Sheet Caption   October 31, 2023   Operating Leases           Right-of-use assets       $ 5,994   Accumulated amortization         (4,787 ) Right-of-use assets, net   Other assets   $ 1,207               Current liabilities   Accrued expenses and deferred revenue   $ 727   Non-current liabilities   Other non-current liabilities     678   Total operating lease liabilities       $ 1,405   Finance Leases           Right-of-use assets       $ 41,631   Accumulated depreciation         (10,580 ) Right-of-use assets, net   Property, plant, and equipment, net   $ 31,051               Current liabilities   Accrued expenses and deferred revenue   $ 1,498   Non-current liabilities   Finance lease payable, net of current portion     36,209   Total finance lease liabilities       $ 37,707
Summary of Future Expected Undiscounted Cash Flows	The following table represents future expected undiscounted cashflows, based on the sublease agreement with AOUT, to be received on an annual basis for the next five years and thereafter, as of October 31, 2023 (in thousands):   Fiscal   Amount   2024   $ 1,399   2025     3,180   2026     3,235   2027     3,292   2028     3,350   Thereafter     38,906   Total future sublease receipts     53,362   Less amounts representing interest     (16,408 ) Present value of sublease receipts   $ 36,954
Summary of Future Lease Payments for Operating and Finance Leases	Future lease payments for all our operating and finance leases for succeeding fiscal years is as follows (in thousands):       Operating     Financing     Total   2024       $ 650     $ 1,675     $ 2,325   2025         324       3,378       3,702   2026         301       3,433       3,734   2027         272       3,490       3,762   2028         125       3,424       3,549   Thereafter         —       38,906       38,906   Total future lease payments         1,672       54,306       55,978   Less amounts representing interest         (267 )     (16,599 )     (16,866 ) Present value of lease payments         1,405       37,707       39,112   Less current maturities of lease liabilities         (727 )     (1,498 )     (2,225 ) Long-term maturities of lease liabilities       $ 678     $ 36,209     $ 36,887

v3.23.3

Inventories (Tables)	6 Months Ended
	Oct. 31, 2023
Inventory Disclosure [Abstract]
Summary of Inventories	The following table sets forth a summary of inventories, net of reserves, stated at lower of cost or net realizable value, as of October 31, 2023 and April 30, 2023 (in thousands):       October 31, 2023     April 30, 2023   Finished goods   $ 95,646     $ 93,705   Finished parts     47,980       65,460   Work in process     7,026       6,821   Raw material     12,639       11,132   Total inventories   $ 163,291     $ 177,118

v3.23.3

Accrued Expenses and Deferred Revenue (Tables)	6 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Summary of Accrued Expenses	The following table sets forth other accrued expenses as of October 31, 2023 and April 30, 2023 (in thousands):   October 31, 2023     April 30, 2023   Accrued taxes other than income   $ 5,250     $ 3,703   Accrued employee benefits     3,339       3,256   Accrued settlement     3,200       —   Accrued distributor incentives     2,931       1,640   Accrued other     2,494       4,597   Accrued professional fees     2,145       2,596   Accrued rebates and promotions     1,613       1,649   Current portion of finance lease obligation     1,498       1,434   Current portion of operating lease obligation     727       1,274   Total accrued expenses and deferred revenue   $ 23,197     $ 20,149

v3.23.3

Stockholders' Equity (Tables)	6 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Reconciliation of Net Income Amounts and Weighted Average Number of Common and Common Equivalent Shares Used to Determine Basic and Diluted Earnings per Share	The following table provides a reconciliation of the net income amounts and weighted average number of common and common equivalent shares used to determine basic and diluted earnings per share for the three months ended October 31, 2023 and 2022 (in thousands, except per share data):   For the Three Months Ended October 31,     2023     2022     Net           Per Share     Net           Per Share     Income     Shares     Amount     Income     Shares     Amount   Basic earnings $   2,498       45,977     $   0.05     $   9,648       45,815     $   0.21   Effect of dilutive stock awards   —       384       —       —       291       —   Diluted earnings $   2,498       46,361     $   0.05     $   9,648       46,106     $   0.21       For the Six Months Ended October 31,     2023     2022     Net           Per Share     Net           Per Share     Income     Shares     Amount     Income     Shares     Amount   Basic earnings $   5,616       46,042     $   0.12     $   12,960       45,777     $   0.28   Effect of dilutive stock awards   —     416       —       —       327       —   Diluted earnings $   5,616       46,458     $   0.12     $   12,960       46,104     $   0.28
Summary of Activity for Unvested RSUs and PSUs	A summary of activity for unvested RSUs and PSUs for the six months ended October 31, 2023 and 2022 is as follows:     For the Six Months Ended October 31,       2023     2022             Weighted           Weighted       Total # of     Average     Total # of     Average       Restricted     Grant Date     Restricted     Grant Date       Stock Units     Fair Value     Stock Units     Fair Value   RSUs and PSUs outstanding, beginning of period     932,705     $ 13.14       827,930     $ 13.30   Awarded     533,940       12.07       423,754   (a)   13.53   Released     (276,977 )     11.43       (281,135 )     13.88   Forfeited     (171,387 )     10.69       (3,996 )     15.23   RSUs and PSUs outstanding, end of period     1,018,281     $ 13.47       966,553     $ 13.23     (a) Includes 43,200 PSUs vested during the six months ended October 31, 2023, in connection with achieving maximum performance targets for the 2019.

v3.23.3

Restructuring (Tables)	6 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Components of restructuring charges	The following table summarizes restructuring charges by line item for the three and six months ended October 31, 2023 and 2022 (in thousands):       For the Three Months Ended October 31,     For the Six Months Ended October 31,       2023     2022     2023     2022   Cost of sales   $ 409     $ 1,735     $ 1,312     $ 2,978   Research and development     —       —       —       3   Selling, marketing, and distribution     774       270       2,969       707   General and administrative     878       1,106       1,692       1,620   Total restructuring charges   $ 2,061     $ 3,110     $ 5,973     $ 5,308     The components of the restructuring charges recorded in our condensed consolidated statements of income were as follows (in thousands):       For the Three Months Ended October 31,     For the Six Months Ended October 31,       2023     2022     2023     2022   Severance and employee-related benefits (a)   $ (49 )   $ 2,505     $ 881     $ 3,658   Relocation (a)     210       179       447       1,062   Public relations     922       —       922       —   Freight     199       —       199       —   Consulting services     246       206       456       266   Employee relations     469       135       926       230   Office rent and equipment     64       86       2,142       92   Total restructuring charges   $ 2,061     $ 3,110     $ 5,973     $ 5,308     a) Recorded in accrued payroll and incentives.
Schedule of Severance and employee related benefit and Relocation accruals	The following table summarizes the activity in the severance and employee-related benefits and relocation accruals for the six months ended October 31, 2023 (in thousands):       Severance and employee-related benefits     Relocation     Total   Accrual at April 30, 2023   $ 10,054     $ 1,746     $ 11,800       Charges     881       447       1,328       Cash payments and settlements     (926 )     (1,395 )     (2,321 ) Accrual at October 31, 2023 (a)   $ 10,010     $ 798     $ 10,808     a) Recorded in accrued payroll and incentives.

v3.23.3

Discontinued Operations - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Income/(loss) from discontinued operations, net of tax	$ 0	$ 0	$ 0	$ 0

v3.23.3

Discontinued Operations - Summary of Major Business Line Items Included in Discontinued Operations in Condensed Consolidation Statements of Income/(Loss) and Comprehensive Income/(Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Income from discontinued operations, net of tax	$ 0	$ 0	$ 0	$ 0

v3.23.3

Leases - Schedule of Assets and Liabilities Related to Operating and Financing Leases (Detail) - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Operating Leases
Right-of-use assets	$ 5,994
Accumulated amortization	(4,787)
Right-of-use assets, net	$ 1,207
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets
Current liabilities	$ 727	$ 1,274
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and deferred revenue	Accrued expenses and deferred revenue
Non-current liabilities	$ 678
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other non-current liabilities
Total operating lease liabilities	$ 1,405
Finance Leases
Right-of-use assets	41,631
Accumulated depreciation	(10,580)
Right-of-use assets, net	$ 31,051
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant, and equipment, net
Current liabilities	$ 1,498	$ 1,434
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and deferred revenue	Accrued expenses and deferred revenue
Non-current liabilities	$ 36,209	$ 36,961
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Non-current liabilities
Total finance lease liabilities	$ 37,707

v3.23.3

Leases - Additional Information (Detail) - USD ($)		3 Months Ended	6 Months Ended
	Jul. 16, 2022	Oct. 31, 2023	Oct. 31, 2023
Lessee Lease Description [Line Items]
Operating lease cost		$ 411,000
Short-term operating lease costs		41,000
Financing lease Amortization		566,000
Financing lease interest expense		$ 475,000
Operating leases, weighted average lease term		2 years 9 months 18 days	2 years 9 months 18 days
Operating leases, weighted average discount rate		4.40%	4.40%
Financing leases, weighted average lease term		14 years 9 months 18 days	14 years 9 months 18 days
Financing leases, weighted average discount rate		5.00%	5.00%
Percentage of sublease	64.70%
Income related to sublease agreement			$ 1,300,000
Cash paid for amounts included in measurement of liabilities and operating cash flows		$ 1,200,000	2,300,000
General and administrative
Lessee Lease Description [Line Items]
Income related to sublease agreement			722,000
Interest Expense
Lessee Lease Description [Line Items]
Income related to sublease agreement			$ 581,000
National Logistics Facility Member
Lessee Lease Description [Line Items]
Percentage of sublease			59.00%

v3.23.3

Leases - Summary of Future Expected Undiscounted Cash Flows (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]
2024	$ 1,399
2025	3,180
2026	3,235
2027	3,292
2028	3,350
Thereafter	38,906
Total future sublease receipts	53,362
Less amounts representing interest	(16,408)
Present value of sublease receipts	$ 36,954

v3.23.3

Leases - Summary of Future Lease Payments for Operating and Finance Leases (Detail) - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Operating And Finance Lease Liabilities Payments Due [Abstract]
2024	$ 2,325
2025	3,702
2026	3,734
2027	3,762
2028	3,549
Thereafter	38,906
Total future lease payments	55,978
Less amounts representing interest	(16,866)
Present value of lease payments	39,112
Less current maturities of lease liabilities	(2,225)
Long-term maturities of lease liabilities	36,887
Operating Leases
2024	650
2025	324
2026	301
2027	272
2028	125
Thereafter	0
Total future lease payments	1,672
Less amounts representing interest	(267)
Present value of lease payments	1,405
Less current maturities of lease liabilities	(727)	$ (1,274)
Long-term maturities of lease liabilities	678
Financing Leases
2024	1,675
2025	3,378
2026	3,433
2027	3,490
2028	3,424
Thereafter	38,906
Total future lease payments	54,306
Less amounts representing interest	(16,599)
Present value of lease payments	37,707
Less current maturities of lease liabilities	(1,498)	(1,434)
Finance Lease, Liability, Noncurrent	$ 36,209	$ 36,961

v3.23.3

Notes, Loans Payable, and Financing Arrangements - Additional Information (Detail) - USD ($)		6 Months Ended
	Aug. 24, 2020	Oct. 31, 2023
Maximum
Debt Instrument [Line Items]
Swingline Loan	$ 5,000,000
Swingline Loan
Debt Instrument [Line Items]
Interest description of revolving line of credit		Each Swingline Loan (as defined in the Amended and Restated Credit Agreement) bears interest at the Base Rate, plus an applicable margin based on our Adjusted Consolidated Leverage Ratio (as defined in the Amended and Restated Credit Agreement).
Credit facility additional borrowing capacity option to increase maximum borrowing capacity	50,000,000
Unsecured Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity	$ 100,000,000
Interest description of revolving line of credit		the Revolving Line. The Revolving Line bears interest at either the Base Rate (as defined in the Amended and Restated Credit Agreement) or the SOFR rate, plus an applicable margin based on our consolidated leverage ratio.
Credit facility, maturity	Aug. 24, 2025
Credit Facilities
Debt Instrument [Line Items]
Borrowings outstanding		$ 65,000,000
Line Of Credit Facility Interest Capitalised		665,000
Outstanding letters of credit		2,700,000
Credit Facilities | Self Insurance
Debt Instrument [Line Items]
Outstanding letters of credit		$ 1,500,000
Credit Facilities | London Interbank Offered Rate
Debt Instrument [Line Items]
Interest rate on borrowings		7.17%

v3.23.3

Fair Value Measurement - Additional Information (Detail) - USD ($)	Oct. 31, 2023	Apr. 30, 2023
(Level 1) | Fair Value on Recurring Basis
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 44,200,000	$ 53,600,000
(Level 2)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	0
(Level 3)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	$ 0

v3.23.3

Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 95,646	$ 93,705
Finished parts	47,980	65,460
Work in process	7,026	6,821
Raw material	12,639	11,132
Total inventories	$ 163,291	$ 177,118

v3.23.3

Accrued Expenses and Deferred Revenue - Summary of Accrued Expenses (Detail) - USD ($) $ in Thousands	Oct. 31, 2023	Apr. 30, 2023
Payables and Accruals [Abstract]
Accrued taxes other than income	$ 5,250	$ 3,703
Accrued employee benefits	3,339	3,256
Accrued settlement	3,200	0
Accrued distributor incentives	2,931	1,640
Accrued other	2,494	4,597
Accrued professional fees	2,145	2,596
Accrued rebates and promotions	1,613	1,649
Current portion of finance lease obligation	$ 1,498	$ 1,434
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Total accrued expenses and deferred revenue	Total accrued expenses and deferred revenue
Current portion of operating lease obligation	$ 727	$ 1,274
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Total accrued expenses and deferred revenue	Total accrued expenses and deferred revenue
Total accrued expenses and deferred revenue	$ 23,197	$ 20,149

v3.23.3

Stockholders' Equity - Additional Information (Detail) - USD ($)		3 Months Ended		6 Months Ended
		Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Sep. 19, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense				$ 2,800,000	$ 2,600,000
Performance period				3 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive shares excluded from computation of diluted earnings per share		15,719,000	23,264,000	18,028,000	25,730,000
Vesting period				4 years
Vesting, percentage				25.00%
Stock units, awarded				357,357	286,218
Stock units, forfeited				13,287	3,996
RSUs | Non-Executive Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded				180,814	157,227
RSUs | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded				58,819	56,497
RSUs | Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded				117,724	72,494
Grant date fair value of vested RSUs and PSUs				$ 6,500,000	$ 3,900,000
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Percentage Of Target Award Granted For Calculating Maximum Aggregate Award Of Performance Share					200.00%
Stock units, awarded					28,800
Performance Shares | Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded				176,583	108,736
Grant date fair value of vested RSUs and PSUs				$ 664,000	$ 1,200,000
Performance Shares | Excecutive And Former Executive Officer Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded					57,600
RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, awarded	[1]			533,940	423,754
Stock units, forfeited				171,387	3,996
Unrecognized compensation expense related to unvested RSUs and PSUs		$ 6,000,000		$ 6,000,000
Weighted average remaining contractual term				1 year 8 months 12 days
Service based PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units, forfeited				158,100
Share Repurchase Transactions Two [Member] | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase authorization						$ 50,000,000
Repurchase of common stock		645,770
Number of shares repurchased, value		$ 8,200,000
[1] Includes 43,200 PSUs vested during the six months ended October 31, 2023, in connection with achieving maximum performance targets for the 2019.

v3.23.3

Stockholders' Equity - Reconciliation of Net Income Amounts and Weighted Average Number of Common and Common Equivalent Shares Used to Determine Basic and Diluted Earnings per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Net income
Income from continuing operations	$ 2,498	$ 9,648	$ 5,616	$ 12,960
Income from discontinued operations	0	0	0	0
Net income	$ 2,498	$ 9,648	$ 5,616	$ 12,960
Weighted average shares outstanding — Basic	45,977	45,815	46,042	45,777
Effect of dilutive stock awards	384	291	416	327
Weighted average shares outstanding — Diluted	46,361	46,106	46,458	46,104
Earnings per share - Basic
Net income	$ 0.05	$ 0.21	$ 0.12	$ 0.28
Earnings per share - Diluted
Net income	0.05	0.21	0.12	0.28
Earnings Per Share - Effect of Dilutive Stock Awards
Effect of dilutive stock awards	$ 0	$ 0	$ 0	$ 0

v3.23.3

Stockholders' Equity - Summary of Activity for Unvested RSUs and PSUs (Detail) - $ / shares		6 Months Ended
		Oct. 31, 2023	Oct. 31, 2022
Summary of activity in unvested restricted stock units and performance share units
Restricted Stock Units, Vested		(43,200)
RSUs and PSUs
Summary of activity in unvested restricted stock units and performance share units
Restricted Stock Units, RSUs and PSUs outstanding, beginning of period		932,705	827,930
Restricted Stock Units, Awarded	[1]	533,940	423,754
Restricted Stock Units, Vested		(276,977)	(281,135)
Restricted Stock Units, Forfeited		(171,387)	(3,996)
Restricted Stock Units, RSUs and PSUs outstanding, end of period		1,018,281	966,553
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, RSUs and PSUs outstanding, beginning of period		$ 13.14	$ 13.3
Weighted Average Grant Date Fair Value, Awarded	[1]	12.07	13.53
Weighted Average Grant Date Fair Value, Vested		11.43	13.88
Weighted Average Grant Date Fair Value, Forfeited		10.69	15.23
Weighted Average Grant Date Fair Value, RSUs and PSUs outstanding, end of period		$ 13.47	$ 13.23
[1] Includes 43,200 PSUs vested during the six months ended October 31, 2023, in connection with achieving maximum performance targets for the 2019.

v3.23.3

Stockholders' Equity - Summary of Activity for Unvested RSUs and PSUs (Parenthetical) (Detail)	6 Months Ended
	Oct. 31, 2023 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock unit vested	43,200

v3.23.3

Commitments and Contingencies - Additional Information (Detail)		1 Months Ended	6 Months Ended
	Mar. 31, 2022 Plaintiff	Jan. 31, 2018 USD ($)	Oct. 31, 2023 USD ($) Claim Plaintiff	Feb. 02, 2023 USD ($)
Schedule Of Commitments And Contingencies [Line Items]
Compensatory damages sought		$ 18,600,000
Number of Product liability cases | Claim			5
Number Of Other Product Liability Claims | Claim			5
Year Of Other Product Liability Claim			December 2019
Number of plaintiffs | Plaintiff	2
Cost of machinery and equipment			$ 160,000,000
Cost of machinery and equipment, fisal year			$ 170,000,000
Construction Contract Cost				$ 114,533,853
IDB
Schedule Of Commitments And Contingencies [Line Items]
Terms of commitment			County and the cities of Alcoa and Maryville, Tennessee, a public, nonprofit corporation organized and existing under the laws of the state of Tennessee, or the IDB. Pursuant to the Project Agreement, we represented to the IDB that we intend to incur, or cause to be incurred, no less than $120.0 million in aggregate capital expenditures on or before December 31, 2025, create no less than 620 new jobs, and sustain an average hourly wage of at least $25.97 at the facility. Further, pursuant to the Project Agreement, we are required to, among other things, (A) execute a facility lease and an equipment lease with the IDB; (B) cause the construction of the new facility at our sole cost and expense to commence on or before May 31, 2022; (C) incur, or cause to be incurred, aggregate capital expenditures in connection with the construction and equipping of the new facility in an aggregate amount of not less than $120.0 million on or before December 31, 2025; (D) cause the construction of the new facility to be substantially completed and for a certificate of occupancy to be issued therefore on or before December 31, 2023; (E) provide the IDB with a written report certified by one of our authorized officers, not later than January 31 of each year during the period between January 31, 2024 and January 31, 2031; and (F) make certain payments to IDB in the event that our actual capital expenditures, number of employees, or average hourly wage of such employees are less than our projections.
Minimum
Schedule Of Commitments And Contingencies [Line Items]
Compensatory damages sought			$ 75,000
Maximum
Schedule Of Commitments And Contingencies [Line Items]
Compensatory damages sought			$ 50,000,000
Putative Class
Schedule Of Commitments And Contingencies [Line Items]
Number of plaintiffs | Plaintiff			2
Putative Class | General Damages
Schedule Of Commitments And Contingencies [Line Items]
Aggregate damages claims			$ 50
Putative Class | Compensatory or Punitive Damages
Schedule Of Commitments And Contingencies [Line Items]
Aggregate damages claims			100
Equipment [Member]
Schedule Of Commitments And Contingencies [Line Items]
Asset Impairment Charges, Total			$ 1,900,000

v3.23.3

Restructuring (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 2,061	$ 3,110	$ 5,973	$ 5,308
Cost of Goods Sold [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 409	$ 1,735	$ 1,312	$ 2,978

v3.23.3

Restructuring - Components of Restructuring Charges (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		$ 2,061	$ 3,110	$ 5,973	$ 5,308
cost of sales
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		409	1,735	1,312	2,978
Research and development
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		0	0	0	3
Selling, marketing, and distribution
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		774	270	2,969	707
General and administrative
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		878	1,106	1,692	1,620
Severance and Employee-Related Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	[1]	(49)	2,505	881	3,658
Relocation [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	[1]	210	179	447	1,062
Public relations [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		922	0	922	0
Freight [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		199	0	199	0
Consulting Services [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		246	206	456	266
Employee Relations [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		469	135	926	230
Office Rent and Equipment [Member]
Restructuring Cost and Reserve [Line Items]
Total restructuring charges		$ 64	$ 86	$ 2,142	$ 92
[1] Recorded in accrued payroll and incentives.

v3.23.3

Restructuring - Restructuring and relocation accrual (Details) $ in Thousands	6 Months Ended
	Oct. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Accrual, Beginning Balance	$ 11,800
Charges	1,328
Cash payments and settlements	(2,321)
Accrual, Ending Balance	10,808	[1]
Relocation [Member]
Restructuring Cost and Reserve [Line Items]
Accrual, Beginning Balance	1,746
Charges	447
Cash payments and settlements	(1,395)
Accrual, Ending Balance	798	[1]
Severance and employee relateds benefits [Member]
Restructuring Cost and Reserve [Line Items]
Accrual, Beginning Balance	10,054
Charges	881
Cash payments and settlements	(926)
Accrual, Ending Balance	$ 10,010	[1]
[1] Recorded in accrued payroll and incentives.

---